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Endocycles are variant cell cycles comprised of DNA Synthesis (S)- and Gap (G)-
phases but lacking mitosis1,2.  Such cycles facilitate post-mitotic growth in many 
invertebrate and plant cells, and are so ubiquitous that they may account for up to half 
the world’s biomass3,4.  DNA replication in endocycling Drosophila cells is triggered 
by Cyclin E/Cyclin Dependent Kinase 2 (CycE/Cdk2), but this kinase must be 
inactivated during each G-phase to allow the assembly of pre-Replication Complexes 
(preRCs) for the next S-phase5,6.  How CycE/Cdk2 is periodically silenced to allow re-
replication has not been established. Here, using genetic tests in parallel with 
computational modeling, we show that Drosophila’s endocycles are driven by a 
molecular oscillator in which the E2F1 transcription factor promotes CycE expression 
and S-phase initiation, S-phase then activates the CRL4Cdt2 ubiquitin ligase, and this in 
turn mediates the destruction of E2F17. We propose that it is the transient loss of E2F1 
during S-phases that creates the window of low Cdk activity required for preRC 
formation. In support of this model over-expressed E2F1 accelerated endocycling, 
whereas a stabilized variant of E2F1 blocked endocycling by de-regulating target 
genes including CycE, as well as Cdk1 and mitotic Cyclins. Moreover, we find that 
altering cell growth by changing nutrition or TOR signaling impacts E2F1 translation, 
thereby making endocycle progression growth-dependent. Many of the regulatory 
interactions essential to this novel cell cycle oscillator are conserved in animals and 
plants1,2,8, suggesting that elements of this mechanism act in most growth-dependent 
cell cycles. 
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S-phase control in proliferating animal cells depends upon the E3 ubiquitin ligase, 
APCFzy/Cdc20, which is activated by Cyclin/Cdk1 during mitosis. APCFzy/Cdc20 promotes 
the degradation of mitotic Cyclins, thereby extinguishing Cdk1 activity following 
mitosis, and it also promotes the degradation of Geminin (Gem), an inhibitor of the 
preRC component Cdt1. The combination of low Geminin and low Cyclin/Cdk1 activity 
during early G1 allows the assembly of preRCs containing origin recognition complex 
(ORC) proteins, Cdc6, Cdt1/Double-parked (Dup), and MCM2-7 onto replication 
origins, thus “licensing” the DNA for renewed replication9.  Drosophila’s endocycling 
cells do not express mitotic Cyclin/Cdk1 complexes or APCFzy/Cdc20 10,11, and so this 
mechanism of S-phase regulation cannot apply to them. These endocycles do 
however employ CycE/Cdk2 to trigger S-phases12,13 (Fig 1, 2), and they also require 
the G1-specific APC variant, APCFzr/Cdh1, which mediates cyclic degradation of cell 
cycle factors including Geminin and Orc110,14. Importantly, while over-expressed 
CycE/Cdk2 is tolerated in mitotic cell cycles15, it blocks endocycling (Fig 2, 3)5,6. This 
is likely due to CycE/Cdk2’s ability to suppress APCFzr/Cdh1 and drive Geminin 
accumulation10,14,16, though CycE may also inhibit preRC formation directly by 
phosphorylating preRC components. The importance of CycE oscillation for 
endocycling is underscored by the finding that Archipelago (Ago/Cdc4/Fbw7), which 
promotes CycE degradation as a component of an SCF ubiquitin ligase, is required for 
the progression of endocycles, but not mitotic cycles (Fig S1)17. Despite its importance 
the mechanism controlling CycE/Cdk2 periodicity in the endocycle has remained 
obscure for over a decade.  
 
We addressed this problem in Drosophila’s larval salivary glands, which undergo ~10 
asynchronous endocycles from ~7-96 hours after egg deposition (h AED), reaching a 
final ploidy of ~1350C18. Studies in the fly ovary had suggested that the CycE/Cdk2 
inhibitor dacapo (dap) might periodically silence Cdk2 during endocycling19, but our 
analysis ruled this out for salivary glands (Fig S2)10. Hence we asked whether cyclic 
CycE/Cdk2 activity might be controlled transcriptionally. CycE transcription is 
regulated by the E2F1 transcription factor20-22, the accumulation of which is periodic in 
mitotic Drosophila cells7,23-25 because it is targeted for degradation during S-phase by 
the PCNA/replication fork-associated E3 ubiquitin ligase CRL4Cdt2 7.  In the salivary 
cells, E2f1 mRNA was ubiquitous (Fig 1c) but E2F1 protein was cyclic, being virtually 
absent in S-phase nuclei (Fig 1d, 2a). Continuously over-expressed E2F1 proteins 
were also depleted from S-phase nuclei (Fig 2c, 3c), consistent with periodic 
degradation. This implied that E2F-dependent transcription might also oscillate. 
Indeed, the mRNAs encoding CycE and two other E2F targets, RnrS and pcna were 
periodic (Fig 1, 3, S15, see also13). These mRNAs accumulated when E2F1 was over-
expressed (Fig 3a) and were reduced in mutants for Dp, E2F1’s obligate dimerization 
partner (Fig S15). Thus periodic CycE expression is likely due to periodic activity of its 
regulator, E2F. CycE protein was also cyclic, being present during a bit of each Gap 
phase and much of each S-phase (Fig 1e)13,26. Based on these and other results10 we 
determined that E2F1 accumulates during G-phases and is destroyed upon entry into 
S-phase, whereas its target CycE rises late in G-phases and persists through most of 
each S-phase. 
 
These observations suggested that endocycles run using a molecular oscillator in 
which E2F1 promotes CycE transcription, and then CycE/Cdk2 triggers S-phase and 
the consequent destruction of E2F1 to reset the cycle (Fig 1g). To evaluate this 
hypothesis we built a computational model that translated known regulatory 
interactions into a system of delay differential equations describing the concentrations 
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of E2F1, RBF, CycE, Geminin, and Cdt1/Dup, and the activities of APCFzr/Cdh1 and 
CRL4Cdt2 (Fig 1g, Supplementary Methods, Fig S4, S5). In this model, when CycE was 
low Gem was degraded by APCFzr/Cdh1, allowing preRC licensing through Cdt1/Dup. 
High CycE suppressed APCFzr/Cdh1 activity and allowed Gem accumulation, and also 
triggered phosphorylation of RBF, S-phase initiation, activation of CRL4Cdt2 and the 
subsequent degradation of E2F1 and Cdt1/Dup. The model’s behavior depended on 
unmeasured parameters representing biochemical kinetics (Table S1), but Monte-
Carlo searches found numerous parameters sets that simulated actual endocycles 
(Fig 1h, i). The model robustly produced oscillations of its components despite 
quantitative parameter variation (Fig S6-9) and did not require exquisitely tuned 
kinetics to reproduce oscillations like those observed in vivo (Supplementary 
Discussion).  
 
We tested the computational model by challenging it to reproduce the results of 
genetic experiments performed in parallel. The model reproduced nearly all observed 
mutant and gene over-expression phenotypes (Fig 2, S10). Notably, it predicted that 
increasing E2F1 should accelerate endocycling and lead to hyper-polyploidy, as 
subsequently observed experimentally (Fig 2, 3, S11). As predicted, we observed 
increased relative DNA amounts in E2f1+/+ cells generated in an E2f1+/- background, 
and found that E2f17172 homozygous null mutant cells supported essentially no 
endocycling (Fig 2b, S13). Thus both loss- and gain-of-function experiments indicated 
that E2F1 is an essential dose-dependent regulator of endocycle progression. 
 
An important prediction of the computational model was that periodic E2F1 destruction 
should be essential for endocycling. Drosophila E2F1 is targeted for proteolysis during 
S-phase via a conserved motif, the PIP box, which binds the replication fork-
associated protein, PCNA, and mediates interaction with the CRL4Cdt2 ubiquitin 
ligase7. Consistent with model predictions, a stabilized but active form of E2F1 lacking 
the PIP box (GFP-E2F1PIP3A)7 blocked endocycle progression (Fig 2, 3, S11). Likewise 
RNAi against Cul4, a CRL4Cdt2 component, arrested endocycling (Fig 2b, S11, S12). 
Levels of E2F1 in cells arrested by GFP-E2F1PIP3A were not higher than in control 
GFP-E2F1-expressing cells that cycled, suggesting that this arrest was due to 
inappropriately timed expression of E2F1 rather than its excessive accumulation (Fig 
3h, S11). Hence S-phase dependent degradation of E2F1 is essential for endocycling.  
 
One discrepancy between the data and our model was that whereas the model could 
not readily predict endocycling without E2F (Fig S10), Dp and E2f1 E2f2 mutants 
support endocycling21,22,26. Our analysis showed that although Dp protein was barely 
detectable in Dp mutant glands (Fig S15) cells in these mutants nevertheless 
endocycled slowly and sustained periodic expression of CycE and RnrS, and Geminin 
oscillation (Fig 2b, S14, S15). One explanation for these apparently discrepant 
observations is that residual maternal E2F activity persists in these mutants. 
Consistent with this possibility we found that GFP-E2F1PIP3A was able to block 
endocycling in Dp mutants (Fig S16). Given this observation, the Dp mutant 
phenotype cannot be construed as confounding the model (see Supplementary 
Discussion).  
 
We next asked how stabilized E2F1 arrests endocycling. Consistent with model 
predictions, cells arrested by GFP-E2F1PIP3A or Cul4-RNAi accumulated CycE and 
Geminin (Fig 3). In these arrested cells, however, Geminin accumulation occurred 
following rather than prior to arrest (Fig S12), indicating that it did not initiate the 
arrest. Interestingly, gem null mutant glands supported rather normal endocycles (Fig 
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S17), but arrest by Rca110,14, an APCFzr/Cdh1 inhibitor, was substantially rescued in the 
gem mutants (Fig 3e, S18). This demonstrates that the predominant function of 
APCFzr/Cdh1 in these endocycles is the degradation of Geminin. Importantly, gem 
mutant cells could be arrested by ectopic CycE10,14 or E2F1PIP3A (Fig 3e, S18, S19). 
We conclude that while Geminin accumulation might consolidate the arrest caused by 
excess E2F1, it is neither initiating nor essential for this arrest. 
 
Further investigations revealed that Cyclin A, Cyclin B3 and Cdk1 accumulated in 
E2F1PIP3A-arrested cells (Fig 3i, S20). These G2/M regulators are not normally 
expressed in endocycling cells8,10. Large inductions of the mRNAs encoding these 
factors were observed (Fig 3h), suggesting transcriptional de-repression. Consistent 
with this notion these factors were also induced in cells mutant for E2f2, Drosophila’s 
repressor E2F (Fig 3i, j). This suggests that, as in mitotic cells27, excess E2F1 may 
displace E2F2 and thereby de-repress its targets. In this context E2F2 appears to act 
as a selectivity factor that represses mitotic targets in endoreplicating cells. Given that 
Cdk1 is a potent suppressor of PreRCs that can arrest endocycle progression6, its de-
repression probably contributed to endocycle arrest by E2F1PIP3A.  
 
Altogether our results indicate that periodic E2F1 degradation is necessary for 
endocycling for three reasons: 1) it creates a window of low CycE/Cdk2 activity; 2) it 
promotes high APCFzr/Cdh1 activity and thereby suppresses Geminin accumulation; and 
3) it allows E2F2 to maintain repression of Cdk1 and its Cyclins. Each of these 
conditions is required for preRC assembly and endocycle progression. This cell cycle 
mechanism (Fig 1g, S4) is fundamentally different from that used in mitotic cycles, 
wherein destruction of the M-phase Cyclins by APCCdc20/Fzy, rather than of E2F1 by the 
CRL4Cdt2, throws the switch that allows preRC assembly9. Indeed it is noteworthy that 
the periodic degradation of E2F1 and depletion of CycE are not required for mitotic cell 
cycles in Drosophila7,12. CRL4Cdt2 is required for endocycling in plants8, suggesting that 
this element of the endocycle oscillator is conserved. 
  
Finally, we asked what factors control E2F production to regulate endocycle rates. 
Endocycle speed and number can be manipulated by altering cell growth through 
changes in dietary protein28 or growth-regulatory genes including dMyc1 and 
Insulin/PI3K/TOR signaling components29. Hence we starved larvae of protein to 
suppress insulin/TOR signaling, reduce protein synthesis, and block cell growth. 
Starvation arrested the salivary endocycles within 24h and strongly depleted E2F1 
(Fig 4a,b). E2f1 and Dp mRNA levels were not affected, but the E2F targets CycE, 
pcna, and rnrS were reduced (Fig 4c, not shown). To test whether this was 
responsible for starvation-induced endocycle arrest we overexpressed E2F1 in the 
salivary glands of starved animals. Although these glands failed to grow their nuclei 
incorporated BrdU and accrued ~7-fold more DNA than controls (Fig 4a). Over-
expression of Rheb, which activates the Target of Rapamycin (TOR) kinase and 
increases ribosome biogenesis and cap-dependent translation, also restored cell 
growth, E2F1 protein, and endocycle progression in starved animals (Fig 4a). Thus 
E2F1 appears to act as a “growth sensor” that couples rates of endocycle progression 
to rates of cell growth. A likely mechanism for this, corroborated by modeling (Fig 4e, 
S8), involves increased translation of E2F1 in rapidly growing cells. Indeed, we found 
that the association of E2F1 mRNA with polyribosomes was greatly reduced in 
protein-starved animals (Fig 4d). Translational control of E2F is an attractive 
mechanism for coupling growth to G1/S progression not only in endocycling cells, but 
also in growth-dependent mitotic cells with extended G1 periods. 
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METHODS SUMMARY 
Larvae were raised at 25oC in uncrowded conditions, and salivary glands dissected 
and analyzed using standard Drosophila genetics and molecular biology methods. 
DNA quantifications were done using DAPI fluorescence from CCD images. 
Computational modeling used delay differential equations tracking the concentrations 
of mRNAs and proteins, and numerically solved in Mathematica 5.2 (Wolfram 
Research). Full descriptions of experimental and computational methods, genotypes, 
and reagents is included in the Online Methods section and Supplementary 
Information. 
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FIGURE LEGENDS 
 
Figure 1. Wildtype salivary gland endocycles. 
a-c) In situ hybridization of WT 72h AED glands to the indicated mRNAs. d-f) WT 
salivary glands at 72h AED double-labeled for:  d) E2F1 (green) and BrdU (red); e) 
CycE (red) and BrdU (green); f) CycE (red) and E2F1 (green).  Graphs show nuclear 
concentrations measured from micrographs of 2-3 glands, in which each dot 
represents one nucleus. Shaded region (blue) shows trajectory of E2F1/CycE 
oscillations with an arrow indicating the expected temporal progression.  g) Simplified 
schematic of the computational model.  See Fig S4.  h) Time plot for WT predicted by 
the model.  i) Nuclear concentrations predicted by the model; arrow represents 
temporal progression.  
 
Figure 2.  Genetic tests of the endocycle mechanism. 
a) Salivary glands (centered) and associated fat body (above or below; FB) from 72h 
AED larvae expressing the indicated genes under ptc-Gal4/UAS control. ptc-Gal4 
expresses in salivary glands but not in fat body. Left column shows DNA (blue) and 
BrdU (red) incorporated from 71-72h AED. Middle column shows E2F1 (green). Right 
column shows E2F1 and BrdU. All images had identical exposures and 
magnifications. Graphs (right) show simulated time plots of E2F1 (green) CycE (red) 
protein levels and CRL4Cdt2 (Cul4-E3) activity (blue) for each genotype. See Table S1 
for parameters.  b) Nuclear DNA values from 96h AED glands. For each genotype 
about 40 nuclei from 6-20 salivary glands were analyzed. Error bars represent 
standard deviations. ptc-Gal4 drove expression of the UAS-linked transgenes 
indicated with a “+”. Dp -/- : Dpa2/Df(2R)Exel7124 mutant.  E2f1-/- : E2f17172 mutant cells 
generated by mitotic recombination. cdk2-/- mutant glands were generated as 
described in methods. c) Salivary glands expressing wild-type GFP-E2F1 (above) or 
GFP-E2F1PIP3A (below). Layout as in a. 
 
Figure 3.  Endocycle arrest by stabilized E2F1. 
a-d) Expression of WT GFP-E2F1 with ptc-Gal4 promoted endocycling with cyclic 
cycE (a) and Gem (c), whereas GFP-E2FPIP3A caused endocycle arrest with uniform 
cycE (b) and Gem (d) expression.  e) C-values per nucleus for the indicated 
genotypes and timepoints. For each genotype about 40 nuclei from 10-20 salivary 
glands were analyzed. Error bars represent standard deviations.  f-g) CycA 
expression in WT (f) and glands expressing WT GFP-E2F1 (f) or GFP-E2FPIP3A (g). 
Arrowhead (f) indicates diploid imaginal ring cells. h) qRT-PCR measurements of the 
indicated mRNAs, from 72h AED salivary glands expressing GFP-E2F1 (green) or 
GFP-E2F1PIP3A (red). i) CycA and Cdk1 accumulation in E2f2 mutant cells, generated 
by MARCM mitotic recombination. GFP in i marks mutant cells (outlined). Cdk1 in i’’’ 
was detected using anti-PSTAIRE antibody. j) qRT-PCR measurements of the 
indicated mRNAs, from E2f2 mutant glands at the indicated timepoints. Log10(Ratio)s 
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for h and j are relative to WT controls. Error bars represent standard deviations 
derived from 3-4 biological replicates. 
 
Figure 4.  E2F1 is a growth sensor. 
a) Salivary glands labeled for DNA (blue), E2F1 (green), and incorporated BrdU (red). 
Fed Control (WT) was labeled with BrdU at 48h and fixed at 49h. “Starved” animals 
were transferred to protein-free media at 48h AED, labeled with BrdU at 96h, and fixed 
at 97h AED. ptc-Gal4 drove expression of UAS-E2F1/DP or UAS-Rheb in the lower 
two panels. Chromatin (C) values are average nuclear DNA values from 10 glands 
measured at 120h AED.  b) Immunoblot of salivary glands as in a, with quantitation, 
normalized to tubulin, below.  c) mRNA levels from starved and fed control glands, 
measured by qRT-PCR. d) mRNA levels from 3d protein-starved (black) or fed control 
(red) whole larvae, quantified from polysome gradient fractions by qRT-PCR. X axis 
indicates gradient fraction number. e) Computational simulation of starvation by 
reducing total protein synthesis (tn). In the “20% tn +E2F1” graph, translation of E2F1 
was 100% of normal but translation of all other proteins was reduced to 20%. Graphed 
values (b, c) include standard deviations calculated from 3 independent biological 
samples. 
 
 
METHODS 
Genetics 
To express genes in salivary glands ptc-Gal4, 43B-Gal4 or hey-Gal4 females were crossed 
to males carrying UAS transgenes. E2f17172/ E2f17172 mutant salivary gland cells were 
generated by heat shocking hs-Flp; FRT82B E2f17172/FRT82B ub-GPF-nls embryos to 37oC 
from 2-4h AED. Cdk2 mutant glands were generated using the genotype: F4-Gal4 UAS-
GFP/+; Cdk2FRT Cdk23/Cdk22 or F4-Gal4 UAS-GFP/UAS-Flp; Cdk2FRT Cdk23/Cdk22, 
where Cdk2FRT is a transgene encoding an Flp-excisable Cdk2. 
 
Mutants: 
w; FRT80B, ago1/TM6B30 
y,w, hs-FLP1.22; FRT80B P[mini-w], P[ubi-GFP]/TM6B 
dap4/CyO, act-GFP31 
dapg36/CyO, act-GFP32 
w; Dpa1 /CyO, act-GFP21 
w; Dpa2 /CyO, act-GFP21 
w; FRT42D, Dpa3 /CyO, act-GFP21,33 
w; Df(2R)Exel7124 /CyO(act-GFP) (Bloomington Drosophila Stock Center #7872) 
w; FRT80B, e2f17172/TM6B (e2f17172 is described in 34) 
w; e2f276Q1, cn, bw/CyO, act-GFP27 
w; FRT40A, e2f2C03344, dpov/CyO, act-GFP (Gift from Maxim Frolov, University of Illinois, 
Chicago/USA) 
w; gemininl(2)k14019,c, px, sp/CyO, act-GFP35 
w; gemininl(2)k02302,c, px, sp/CyO, act-GFP35 
w; DF(2R)ST1, Adhn5, pr1, cn*/ CyO, act-GFP35 
 
For mutants, we used the strongest alleles available, which in most cases are null alleles. 
Details on mutant lesions can be found in the cited papers and FlyBase (http://flybase.org/). 
 
Transgenes: 
ptc-Gal436 
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43B-Gal45 
hey-Gal4, Pin/CyO (Gift from Amir Orian, Rappaport Institute, Israel) 
UASt-Cul4-RNAi (VDRC #44829) 
UASt-CycE31 
UASt-CycE-RNAi (Nig-Fly #3938R-3) 
UASt-Dap31 
UASp-GFP-E2F17 
UASp-GFP-E2F1-PIP3A7 
UASt-E2F115 
UASt-Rbf137  
UASt-Rheb38 
UASt-HA-Rca139 
Starvation 
At 48h or 72h AED larvae were washed with PBS and transferred to PBS+20% sucrose at 
25oC, and maintained on this media until 96h or 120h AED, respectively.  
DNA quantification  
DNA content in nuclei or whole salivary glands was quantified by DAPI fluorescence.  Larvae 
were raised at 25oC to 96h AED, and fixed glands were dissected and stained, using an 
internal control (ptc-Gal4 UAS-GFPnls) for each sample. Samples were imaged at 10x with a 
CCD camera (Spot RT or Roper HQ2). Average cytoplasmic intensity was subtracted, and 
the integrated DAPI intensity was used to measure DNA content for whole glands (Fig 2) or 
nuclei (Fig 3). All salivary glands had ~the same number of cells (<10% variability). Controls 
were set to 1350C according to18.  
Quantification of nuclear concentrations 
Nuclear BrdU, Cyclin E, E2F1, and GFP-E2F1 concentrations as shown in Fig 1(D-F), S3, 
and S11 were measured from samples stained with DAPI and the indicated antibodies and 
imaged by confocal microscopy at 20X. We took image stacks (interval size = 0.65µm; 
optimal overlap under our conditions) with optimized imaging conditions such that the 
deviation from linearity was <10%. To measure average nuclear concentrations of E2F1 and 
CycE, we used ImageJ (NIH) and custom software that searched for nuclei by finding 
ellipsoidal regions that stained brightly for DNA and had the approximate diameter of a 
nucleus. About half of all nuclei visually overlapped with their neighbors and were not 
analyzed. To reproducibly set the boundaries for each nucleus, we restricted our analysis to 
optical sections in which the average nuclear DNA staining was >90% maximal (typically 2-5 
sections). Mean intensity in these regions was measured in other channels to determine 
nuclear concentrations. 
 
BrdU labeling 
Embryos were collected on grape-juice/agar plates for 2h and transferred to regular fly-food 
24h after egg deposition. At the indicated time points salivary glands were dissected in 
Drosophila Ringer’s Solution and incubated for 1h at room temperature with 100µg/ml BrdU 
in Ringer’s Solution. Afterwards, the samples were fixed for 30min in 4% 
Paraformaldehyde/PBS and subsequently treated for 30min with 2N HCl. BrdU incorporation 
was detected with a mouse anti-BrdU antibody (Becton Dickinson) diluted 1:20 in 4% 
NGS/PBS/0.3% Triton-X100 and goat anti-mouse-Alexa Fluor-568 (Invitrogen) as secondary 
antibody diluted 1:2000 in 4% NGS/PBS/0.3% Triton-X100. 
 
EdU labeling 
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EdU incorporation was performed analogous to the procedure for BrdU labeling using the 
Click-It EdU Alexa Fluor-555 imaging kit from Invitrogen. 
 
In situ hybridization 
Probes for in situ hybridization were generated with the DIG RNA labeling system (Roche). 
For in vitro transcription with T7/T3 RNA polymerase the following plasmids were used as 
template: pT7T3-19U-CycE40; pBLu(2)SKM-RnrS41; pBluSKP-E2F142. Salivary glands were 
dissected from larvae staged to the indicated time points. Small batches of about 30 larvae 
were fixed overnight in 8% formaldehyde/PBS, pooled in scintillation vials and stored until 
usage in ethanol at -80˚C. The hybridization procedure was performed according to the 
protocol developed by the Bier-Lab43. For detection samples were probed with the following 
antibodies: sheep-anti-DIG-AP (1:500, Roche) or mouse anti-DIG-HRP (1:500, Abcam). 
BCIP/NBT was used as substrate for the AP reaction according to Tautz & Pfeifle44,  while 
the TSA Alexa Fluor-568 Detection Kit (Invitrogen) was used in combination with HRP. 
 
qRT-PCR 
At the indicated time points about 50 salivary glands per genotype were dissected in 
Drosophila Ringer’s Solution and immediately transferred to the lysis-buffer supplied with the 
RNAeasy mini kit (Qiagen). Samples were stored at -80˚C and then processed with the 
RNAeasy mini kit (Qiagen) according the manufacturers instructions including the optional 
on-column DNAseI digestion. 100ng of total RNA were used for cDNA synthesis with the 
Quantitect Reverse Transcription Kit (Qiagen) or the iScript cDNA synthesis kit (Bio-Rad). 
qRT-PCR data shown in Figure 3 I-K was acquired on a Light Cycler 480 (Roche) using the 
indicated UPL assays (Roche) and Light Cycler 480 Probes Master (Roche). Relative 
expression data presented in Figure 4C was acquired on an iQ5 Instrument (Biorad) using 
QuantiTect Primer Assays (Qiagen) and the iScript one-step RT-PCR SYBR green kit (Bio-
Rad). To ensure statistical significance qRT-PCR was performed in quadruplicates from 3-4 
independent samples. Relative expression to GAPDH1 and Actin5c was determined with the 
∆∆CT method: 
∆CT      =    CTgene of interest - CTendogenous control  
     ∆∆CT =  ∆CTsample – ∆CTcalibrator  
       relative quantity =  2-∆∆CT 
 
Polysome profiling  
Whole larvae were lysed in ice-cold polysome lysis buffer (25mM Tris pH6.8, 10mM MgCl2, 
25mM NaCl, 1% Triton-X 100, 0.5% Sodium Deoxycholate, 0.5uM DTT 1ug/ml 
Cycloheximide, 10ug/ml Heparin, Protease Inhibitor Cocktail (Complete mini, Roche), 2.5 uM 
PMSF, 5mM Sodium Fluoride, 1mM Sodiumorthovanadate, RNase inhibitor (Ribolock, -
Fermentas) using a Dounce Homogenizer. Lysates were then cleared by centrifugation 
(15,000 rpm, 15 mins, 4C). Equal optical density units (260nM) of cleared lysates were then 
layered on 15-45% sucrose gradient (prepared in polysome lysis buffer) and centrifuged 
(37,000 rpm, 2.5 hrs, 4C) in an SW41 Beckman rotor. The gradients were then fractionated 
using a Brandel BR188 Density Gradient fractionator with continuous OD (254nm) reading 
and collected into twelve equal fractions. The RNA from each fraction was extracted with 
Trizol reagent and reversed transcribed using Superscript II (Invitrogen) according to the 
manufacturers instructions. Quantitative real-time PCR was then performed as described in 
45 using a MyIQ PCR machine (BioRad). 
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1. Supplementary Experimental Methods 
 
Generation of ago mutant cells 
ago1 loss of function clones were generated in the salivary placode using mitotic 
recombination. w; FRT80B ago1/TM6B males were crossed to y,w, hs-FLP1.22; FRT80B 
P[mini-w], P[Ubi- GFP]/TM6B1 females. Embryos were collected on grapejuice plates 
for 8h at 25°C and subsequently heat-shocked for 1.5h at 37°C. Heat-shocked samples 
were cultivated 96h at 25°C and then analysed by immunohistochemistry. Primary 
antibodies were used in the following dilutions: guinea pig-anti-CycE (1:500-800; gift of 
T. Orr-Weaver, Whitehead Institute, Cambridge, MA, USA), guinea pig-anti-E2F1 
(1:500, T. Orr-Weaver) and mouse-anti-MPM-2 (1:200, Millipore).  
 
Generation of cdk2 mutant cells 
Cdk2 mutant glands were generated using the genotype: F4-Gal4 UAS-GFP/+; Cdk2FRT 
Cdk23/Cdk22 or F4-Gal4 UAS-GFP/UAS-Flp; Cdk2FRT Cdk23/Cdk22, where Cdk2FRT 
is a transgene encoding an Flp-excisable Cdk2. With this genotype, the animals are 
functionally Cdk2+due to the presence of the Cdk2FRT transgene. In the salivary glands, 
however, F4-Gal4 activates UAS-Flp, and Flp recombinase excises the Cdk2FRT 
wildtype Cdk2 gene from the chromsomes, making all salivary gland cells Cdk23/Cdk23 
mutant. 
Size and DNA-measurement of dap mutants 
Salivary glands were dissected in Ringer’s solution and freed of much fat body as 
possible. The dissected salivary glands were then dissociated for 10 min in lysis buffer 
(0.5% SDS/TE). After centrifugation for 1 min at 14000 rpm, samples were incubated for 
4 min with PicoGreen diluted 1:200 in TE. The fluorescence was then quantified using a 
flourometer (LS50B; Perkin Elmer) with an excitation-wavelength of 480 nm and an 
emission-wavelength of 524 nm. DNA was quantified using a calibration curve (0-150 
ng) based on the DNA-Molecular Weight Marker III (Roche). To measure the area of 
whole larvae or dissected salivary glands, samples where mounted in 87% glycerol and 
imaged with a cooled CCD camera (AxioCam; Zeiss). Images were captured and 
analyzed using IPLab software (Signal Analytics).  
Analysis of embryo extracts by western blotting 
Embryos were collected for 2h at 25˚C. After incubation for 7h 25˚C, embryos were 
dechorionated and then homogenized in Lämmlibuffer. Salivary glands were dissected in 
Ringer’s solution or PBS, and most of the attached fat body was removed. The glands 
were homogenized in Lämmlibuffer and analyzed by western blotting. Extracts were 
separated by SPS-PAGE and transferred to PVDF membranes (Immobilon-FL; 
Millipore) following standard methods. Blots were stained with Ponceau S and then 
probed with following primary antibodies: rabbit-anti-E2F1 (1:50002); rabbit-anti-
Dacapo (1:50003); mouse-anti-α-tubulin (1:3000; Sigma); mouse-anti-α-tubulin 
(1:10000; Developmental Studies Hybridoma Bank #12G10). Appropriate HRP-coupled 
secondary antibodies purchased from Jackson Immunolabs were diluted 1:10000. 
Proteins were visualized using the ECL-Western blotting detection system (Amersham). 
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Comparison of Dp protein levels by western blotting 
Embryos were collected for 2h at 25˚C on grape juice plates, aged for about 24h and then 
transferred into vials with standard fly food. At the indicated time points about 30 
salivary glands were dissected in PBS and subsequently lysed in 1x RIPA (Cell Signaling 
Technology). The lysates were immediately frozen in liquid nitrogen and stored until 
usage at -80˚C. Multiple samples of each genotype were pooled and the amount of total 
protein was then determined with the BCA protein assay kit (Pierce). Equal amounts of 
protein were supplemented with Lämmlibuffer and loaded on a 10% SDS-Gel. The 
separated proteins were subsequently transferred to PVDF membranes (Immobilon-FL; 
Millipore). Blots were stained with Ponceau S and then probed with following primary 
antibodies: rabbit-anti-Dp (1:5000, gift from Nick Dyson, Massachusetts General 
Hospital, Boston, USA); rat-anti-HA (1:1000, Roche); mouse-anti-α-tubulin (1:5000; 
Sigma). Appropriate IR-Dye coupled secondary antibodies were purchased from 
Rockland Immunochemicals and diluted 1:10000. Relative protein amounts were 
determined with the Odyssey Infrared Imaging System (Li-Cor). 
Primers 
 
UPL assays used for qRT-PCR 
Gene Primer  UPL Probe Transcripts 
Actin 5C 
 
agacaccaaaccgaaagacttaat 
acatgccagagccgttgt #132 
Act5C-RA; Act5C-RB; Act5C-
RC; Act5C-RD 
Cdk1 catcaaccgcgatcagaga gcggttctcctccatcaa #88 Cdc2-RA 
Cdk2 gcgcacgaactcataatgtc gaagtaagcgtgctgcagtg 
 
#102 Cdc2c-RA; Cdc2c-RB 
Cyclin A tatttccgggagagcgaga acctcaaccagccaatcaat #58 CycA-RA; CycA-RB 
Cyclin B  gaccactgtagaacccactaaagtt ttggtcagcgacttcttcg #56 
CycB-RA; CycB-RB; CycB-
RC; CycB-RD 
Cyclin B3 gccaagttgcagcaaaagac ctctgggagtgtcagcaaca #5 CycB3-RA 
Cyclin E acaaatttggcctgggacta ggccataagcacttcgtca #43 
CycE-RA; CycE-RB; CycE-
RC; CycE-RD; CycE-RE 
Dp ccgcaaattcgacagagac cgcaacatttcgtttttctg #81 dDP-RA; dDP-RB 
E2F1 gctcaacgtggatctcttcaa  cgccttcacgtaaatctcg #44 E2F-RA; E2F-RB; E2F-RC 
GAPDH1 gctccgggaaaaggaaaa tccgttaattccgatcttcg #102 GAPDH1-RA 
PCNA agccaccatcctgaagaaga gtcgctgcaatcgaaggta #147 PCNA-RA 
RnrS ccatccagtaccacgacatct caaatccacctcctcgacag #30 RnrS-RA 
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Stg cagcatggattgcaatatcagta caacgtcgtcgtcgtagaac #17 Stg-RA 
Gene-specific primers were designed with ProbeFinder software (Roche). 
 
QuantiTect Primer Assays used for qRT-PCR 
Gene QuantiTect Primer Assay Transcripts Amplicon length 
Cyclin E QT01087940 cycE-RA 93bp 
Dp QT00945819 dp-RA 102bp 
E2F1 QT00979931 E2F-RA; E2F-RB; E2F-RC RA:RB:RC 83bp 
PCNA QT00950769 mus209-RA 94bp 
  
Primers for Polysome profiling 
Gene  Primer 
4E-BP  
GCTAAGATGTCCGCTTCACC 
CCTCCAGGAGTGGTGGAGTA 
RPL1  
                  TGGCCTCATCAAACATCAAA 
AAAAGGTTTGCCAACGTCAC 
E2F1 
 CTTCCTCTGCCATGACACCT 
TATTCAGGCTGGGACTGCTT 
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2. Supplementary Computational Methods:  
The endocycle network 
Oscillations in E2F1 and CycE protein levels arise from a complex network of 
interactions summarized in Fig S4. Here we describe our assumptions and the qualitative 
details of these interactions as implemented in the mathematical model. In this section, 
capitalized gene names refer to proteins, E2F1 refers to the active E2F1/Dp protein 
dimer, Cul4 is the CRL4Cdt2 complex, Dup is Dup/Cdt1 and CycE is Cyclin E/Cdk2.   
Briefly, our model tracks the concentrations of the following proteins: E2F1, Rbf, CycE, 
Gem, Dup, their dimers (E2F1/Rbf and Dup/Gem), and the fraction of APCfzr and 
CRL4Cdt2 that are active. The model also tracks the fraction of ORIs that are unlicensed, 
licensed (in a PreRC), and actively replicating (i.e. in S-phase). The mRNA 
concentrations from constitutively transcribed genes rapidly approach an unchanging 
steady state, and we assume a constant rate of synthesis of constitutively produced 
proteins.  
Generation of E2F1 and CycE oscillations: 
The e2f gene encodes a transcription factor that regulates many cell cycle genes.  In our 
model, we assume E2F1 protein is synthesized at a constant rate. E2F1 associates with 
Dp, which is required for its activity. We do not explicitly model levels of Dp protein, 
and assume it is present in excess so that all E2F1 protein is immediately active upon 
synthesis. E2F1 is a powerful regulator of CycE transcription with regulation as follows: 
We assume CycE is transcribed at a low basal rate in the absence of E2F1. Free E2F1 
increases the rate of CycE transcription, while E2F1/Rbf dominantly inhibits 
transcription (i.e. high levels of E2F1/Rbf will block all CycE transcription). Rbf protein, 
like E2F1, is constitutively produced at a constant rate. The effects of E2F2 and Rbf2 are 
not included in our model because too little is known about their regulation and 
interactions to include them meaningfully. Our model incorporates an explicit time delay 
between transcriptional activation of CycE transcription and the appearance of active 
CYCE protein because there is a temporal delay that arises from transcription, translation, 
and transport.    
CycE is a key regulator of the endocycle, and is key for periodic expression of E2F1 and 
CycE. CycE protein can indirectly influence its own expression through Rbf. When CycE 
is present at high levels; it phosphorylates Rbf and dramatically lowers its affinity for 
E2F1, resulting in release of bound E2F1. We assume there is a slow, continuous 
dephosphorylation of phosphorylated RBF and that newly synthesized Rbf protein is not 
phosphorylated. Additionally, at high levels, CycE triggers the firing of PreRC 
complexes to initiate S-phase that in turn activate  CRL4Cdt2. Cul4 rapidly degrades E2F1 
(and Dup, described below), and we assume CRL4Cdt2 is inactivated at a constant rate 
after S-phase is complete. 
These interactions generate E2F1/CycE oscillations as follows: At the start of G-phase, 
E2F1 and CycE levels are low. E2F1 is synthesized and begins to accumulate (some 
binds Rbf) and eventually results in CycE transcription and accumulation of CycE 
protein. This CycE protein phosphorylates Rbf and causes it to release its bound E2F1, 
producing additional CycE transcriptional activation. Once CycE levels are high enough, 
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S-phase is triggered and  CRL4Cdt2 degrades E2F1. In the absence of E2F1 activation, 
CycE protein levels fall during S-phase, returning the E2F1 and CycE concentrations to 
low levels by the start of the next G-phase. 
Regulation of licensing and S-phase: 
At the start of G-phase, the ORIs are in an unlicensed state, and the PreRC complex must 
be assembled before replication can begin. For simplicity, our model requires only Dup 
for PreRC formation, as Dup is required for PreRC formation in endocycling cells. We 
assume Dup is constitutively synthesized at a constant rate, and binds to unlicensed 
ORCs to form the PreRC complex. These PreRC complexes are then ‘fired’ by high 
levels of CycE at the start of S-phase. After a fixed delay (to represent the time for DNA 
replication), the ORIs return to the unlicensed state. 
However, licensing (PreRC formation) and S-phase are usually separate processes that do 
not temporally overlap. Gem protein inhibits Dup by binding to it so it cannot be 
incorporated into the PreRC, and Gem is present at high levels during S-phase due to 
CycE activity: APCfzr degrades Gem protein while it is active during G-phase. During S-
phase, APCfzr is phosphorylated and inactivated by CycE/Cdk2, allowing Gem to 
accumulate. Phosphorylation of Fzr and consequential inactivation by CycE/Cdk2 has 
been directly demonstrated with mammalian cells4, though not in Drosophila5, where the 
evidence is indirect6. Additionally, S-phase activates CRL4Cdt2 that degrades Dup (both 
free Dup or Dup bound to Gem). This regulation of PreRC formation ensures that PreRC 
formation is allowed during G-phase when CycE is low, but during S-phase the PreRCs 
are fired and relicensing is not allowed until after S-phase is complete.   
Modeling tools 
We translated the interactions shown in Fig S4 into a system of delay differential 
equations that tracked the time evolution of the concentrations of endocycle network gene 
products (mRNA and proteins). These equations were numerically solved in Mathematica 
Version 5.2 (Wolfram Research). The network is available as a Mathematica notebook 
file upon request or from: 
http://celldynamics.org/celldynamics/downloads/simCode/Endocycle.zip  
Mathematical approach 
In this section we describe the mathematical details of our implementation of the 
endocycle model. Each equation in the endocycle model expresses the rate of change for 
a given biomolecule concentration (mRNA, protein, ORI state, or complex) as the sum of 
processes representing synthesis, decay, and conversion. We assume that reactions occur 
in well-stirred environments and that concentration (rather than absolute number of 
molecules or some other quantity) determines the reaction kinetics. These equations 
follow the same general form described previously7-10. Enzymatic and transcriptional 
activation kinetics are modeled with sigmoidal functions11: 
! 
" A[ ],k,#( ) = A[ ]
#
$# + A[ ]#
        (1) 
where [A] is the concentration of the regulator, 
! 
"  is the regulator concentration at which 
the reaction proceeds at half the maximal rate, and 
! 
"  is the apparent cooperativity. This 
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formalism allows us to capture the envelope of possible activation curves. As described 
in the results section below, the ability of the endocycle network to reproduce wild-type 
oscillations does not require precise tuning of these parameters, indicating these 
oscillations do not hinge upon our specific choice of parameterization.  
We were interested in relative changes in protein levels, not the absolute concentrations 
or changes on an absolute time scale. Maximal transcriptional and translational rates (Ce, 
Le, etc.) changed only the scaling of the concentrations; these parameters could be 
constrained allowing us to reduce the number of free parameters while still exploring the 
full dynamic behavior of the network. The maximum transcriptional and translational 
synthesis rates were fixed at the reciprocal of the mean lifetimes when we searched for 
parameter sets that could reproduce lifelike behavior. Specifically, we set: 
! 
Cx =
1
Hx
          (2a) 
! 
Lx =
1
HX
          (2b) 
Where Cx is the transcription rate of gene x, Lx is the translation rate, Hx is the mean 
lifetime of the transcript and HX is the mean lifetime of the protein. This amounted to a 
partial nondimensionalization that normalizes concentrations to their maximal steady 
state as described previously7,8,11,12. The concentrations of E2F1 protein, CycE 
mRNA, and CycE protein followed this scheme; Rbf, Dup and Gem proteins were 
allowed to vary over a larger range to allow for the possibility of stoichiometric 
differences between dimerizing partners (i.e. a molar excess of Rbf over E2F1). Maximal 
synthesis rates appear explicitly in the model (as opposed to completely removing them 
by nondimensionalization) because they allowed us to easily simulate the effects of gene 
dosage changes. 
Time delays 
Our model incorporated two fixed time delays. The first delay was in CycE transcription 
and translation to capture the temporal delay between the initiation of CycE transcription 
and the appearance of the CycE protein. The second was a time delay between the 
initiation of S-phase when PreRC’s were fired by CycE and the completion of replication.  
We included delays because they can strongly affect the behavior of oscillators13. Based 
on the CycE gene and transcript lengths, and on estimates of the transcription and 
translation elongation rates and transport/processing times, we estimate these delays at 
tens of minutes14,15 or about 5-20% of a cycle. We allowed a longer period for the S-
phase delay, as experiments indicate that S-phase lasts about 1/3 of the cycle.  The form 
of the model allows for S-phase to end prior to the loss of CycE if DNA is replicated 
quickly, but in cases where CycE levels drop during S-phase, the loss of CycE will end S-
phase. This latter scenario was suggested to occur in nurse cell endocycles by Lilly and 
Spradling16, and to account for under-replication of heterochromatin.  
Delays were implemented as described17. Briefly, the delayed concentration 
! 
X(t "#t)[ ]  
was calculated from the non-delayed concentration 
! 
X(t)[ ]  using a cascade of N equations 
to produce a fixed delay of Δt using 
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! 
X(t "#t)[ ] $ delXN (t)[ ]  (3) 
with 
! 
delX1(t)[ ]
dt =
N delX1(t)[ ] " X(t)[ ]( )
#t  (3a) 
! 
delXn+1(t)[ ]
dt =
N delXn+1(t)[ ] " delCn (t)[ ]( )
#t       (3b) 
where 
! 
delX1(t)[ ]  is approximately 
! 
X1(t "
#t
N )
$ 
% & 
' 
( ) 
,   
! 
n =1,2,!,N  and each successive 
! 
delXn (t)[ ]  is further delayed by 
! 
"t
N : 
[ ] ⎥⎦
⎤
⎢⎣
⎡ Δ
−≈ )(X)(delX
N
tnttn         (3c) 
Equation 3 approximates a sequential process where a molecule transitions between 
many intermediates. Fig S5 shows a plot of CycE mRNA and its delayed versions that 
correspond elongating mRNA of increasing lengths. Our method of implementing a delay 
is similar to a series of lowpass filters, and results in a slight attenuation of high 
frequencies, with the filtering becoming more severe as N decreases. Biologically, some 
lowpass filtering is expected due to the stochastic nature of elongation and transport, so 
Equation 3 is more realistic than a pure fixed time delay. We set N high enough so that it 
did not alter the behavior of our model: we used a cascade with N = 10, and models with 
higher N required more computer time to calculate but did not produce altered hit rates or 
change the ability of the model to reproduce experiment. 
Endocycle model equations 
The full mathematical model is shown below. For visual clarity, parameters are italicized; 
concentrations of molecules (dependent variables) are not italicized and are enclosed by 
brackets. Concentrations of mRNAs are lowercase, and their corresponding proteins are 
in uppercase. RBFp is phosphorylated Rbf, ER is the E2F1/Rbf heterodimer, ERp is the 
E2F1/RBFp heterodimer, and GD is the Gem/Dup heterodimer. CUL and APC refer to 
the fraction of active CRL4Cdt2 and APCfzr respectively, and vary from 0-1. We assume 
that CRL4Cdt2 and APC are long-lived complexes that cycle between active & inactive 
forms. The values of U, PreRC, and S represent the fraction of ORIs that are unlicensed, 
licensed, and in S-phase, respectively; their sum is always 1. When time delays are 
present, we explicitly write the time dependence (and delay). All concentrations are 
initially 0 except for U and APC, which are initially 1 (i.e. all RCs are fully unlicensed 
and all APC is active).  Perturbing these initial conditions over biologically reasonable 
values did not alter the steady state model behavior.  Parameters are defined in Table S1.  
Table S1 also gives the parameter values used to generate all model output plots in the 
main paper and supplement. 
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Notation: 
! 
Cx = Transcription rate of x
Lx = Translation rate of X
"Xy = Half maximal activity of X on Y
#Xy = Cooperativity (Hill coefficient) of X on Y
KXY = Dimerization on/off rate of X and Y
rXy = Maximal rate of process regulated by X on target Y
HX = Mean lifetime of X
$ =1%&
 
! 
d E2F[ ]
dt = Le + KER ER[ ] + KERp ERp[ ] "  rCULe E2F[ ] # CUL[ ],$CULe,%CULe( ) "KRE E2F[ ] RBF[ ] "
E2F[ ]
HE
 (4) 
! 
d RBF[ ]
dt = Lr " rCr RBF[ ] # CYCE[ ],$Cr,%Cr( ) + KER ER[ ] "KRE E2F[ ] RBF[ ] + rDr RBFp[ ] "
RBF[ ]
HR
 (5) 
! 
d RBFp[ ]
dt = rCr RBF[ ] " CYCE[ ],#Cr,$Cr( ) + KERp ERp[ ] % rDr RBFp[ ] %
RBFp[ ]
HR
 (6) 
! 
d ER[ ]
dt = KRE E2F[ ] RBF[ ] + rDr ERp[ ] " rCr ER[ ]  # CYCE[ ],$Cr,%Cr( ) "KER ER[ ] "
ER[ ]
HR
 (7) 
! 
d ERp[ ]
dt = rCr ER[ ]  " CYCE[ ],#Cr,$Cr( ) % rDr ERp[ ] %KERp ERp[ ] %
ERp[ ]
HR
 (8) 
! 
d cyce[ ]
dt = Cc" ER[ ],#Rc,$Rc( )
1%CCc( )
E2F[ ]
#Ec
& 
' 
( 
) 
* 
+ 
$ Ec
E2F[ ]
#Ec
& 
' 
( 
) 
* 
+ 
$ Ec
+
ER[ ]
#Rc
& 
' 
( 
) 
* 
+ 
$ Rc
+1
+ CCc
& 
' 
( 
( 
( 
( ( 
) 
* 
+ 
+ 
+ 
+ + 
%
cyce[ ]
Hc
 
 
(9) 
! 
d CYCE[ ]
dt = Lc cyce t "#tC( )[ ] "
CYCE[ ]
HC
 (10) 
! 
d APC[ ]
dt = rA 1" APC[ ]( ) " rCa APC[ ]# CYCE[ ],$Ca ,%Ca( )
 (11) 
! 
d GEM[ ]
dt = Lg + KDG GD[ ] +
GD[ ]
HD
+ rCULd GD[ ]" CUL[ ],#CULd ,$CULd( ) %KGD GEM[ ] DUP[ ]
% rAg GEM[ ]" APC[ ],#Ag ,$Ag( ) %
GEM[ ]
HG
 
 
(12) 
! 
d DUP[ ]
dt = Ld + KDG GD[ ] + rAg GD[ ]" APC[ ],#Ag,$Ag( ) %KUD U[ ] DUP[ ] %KGD GEM[ ] DUP[ ]
% rCULd DUP[ ]" CUL[ ],#CULd ,$CULd( ) %
DUP[ ]
HD
  
(13) 
! 
d GD[ ]
dt = KGD GEM[ ] DUP[ ] "KDG GD[ ] " rCULd GD[ ]# CUL[ ],$CULd ,%CULd( )
" rAg GD[ ]# APC[ ],$Ag,%Ag( ) "
GD[ ]
HG
"
GD[ ]
HD
 
(14) 
! 
d CUL[ ]
dt = rSc 1" CUL[ ]( )# S[ ],$Sc,% Sc( ) "
CUL[ ]
HCUL
 (15) 
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! 
d U[ ]
dt = rCs PreRC t "#tS( )[ ]$ CYCE t "#tS( )[ ],%Cs,&Cs( ) "KUD U[ ] DUP[ ]
 (16) 
! 
d PreRC[ ]
dt = KUD U[ ] DUP[ ] " rCs PreRC[ ]# CYCE[ ],$Cs,%Cs( )
 (17) 
! 
S[ ] =1" U[ ] " PreRC[ ]  (18) 
 
Equations in endocycle model variants: 
We also explored several model variants shown in Fig S4 that implemented additional or 
alternative regulation and modified the system of equations. These are described in the 
paragraphs below. 
 
Models allowing E2F1 to regulate transcription of Dup (cyan lines). Replace Equation 12 
with: 
! 
d dup[ ]
dt = Cd" ER[ ],#Rd ,$Rd( )
1%CCd( )
E2F[ ]
#Ed
& 
' 
( 
) 
* 
+ 
$ Ed
E2F[ ]
#Ed
& 
' 
( 
) 
* 
+ 
$ Ed
+
ER[ ]
#Rd
& 
' 
( 
) 
* 
+ 
$ Rd
+1
+ CCd
& 
' 
( 
( 
( 
( ( 
) 
* 
+ 
+ 
+ 
+ + 
%
dup[ ]
Hd
    (19) 
! 
d DUP[ ]
dt = Ld dup t "#tC( )[ ] + KDG GD[ ] + rAg GD[ ]$ APC[ ],%Ag ,&Ag( ) "KUD U[ ] DUP[ ] "KGD GEM[ ] DUP[ ]
" rCULd DUP[ ]$ CUL[ ],%CULd ,&CULd( ) "
DUP[ ]
HD
 (20) 
Models with simplified PreRC formation (blue line) abstracted the effects of the 
APC/GEM activity so that CycE blocked PreRC formation directly. Here, we eliminated 
APC, GEM & GD (Equations 11, 12, & 14), and replaced Equations 13, 16, and 17 with: 
! 
d DUP[ ]
dt = Ld "KUD U[ ] DUP[ ]# CYCE[ ],$Cp ,%Cp( ) " rCULd DUP[ ]& CUL[ ],$CULd ,%CULd( ) "
DUP[ ]
HD
  (21) 
! 
d U[ ]
dt = rCs PreRC t "#tS( )[ ]$ CYCE t "#tS( )[ ],%Cs,&Cs( ) "KUD U[ ] DUP[ ]' CYCE[ ],%Cp ,&Cp( )
  (22) 
! 
d PreRC[ ]
dt = KUD U[ ] DUP[ ]" CYCE[ ],#Cp ,$Cp( ) % rCs PreRC[ ]& CYCE[ ],#Cs,$Cs( )
    (23) 
In our standard model, delays from transcription and translation of CycE were combined 
in Equation 9. A model with separate transcriptional and translational delays (
! 
"tCtr  and 
! 
"tCtl  respectively) had no change in behavior, but was slower to solve. In this model, 
Equations 9 and 10 are replaced by: 
! 
d cyce[ ]
dt = Cc" ER t #$tCtr( )[ ],%Rc,&Rc( )
1#CCc( )
E2F t #$tCtr( )[ ]
%Ec
' 
( 
) ) 
* 
+ 
, , 
& Ec
E2F t #$tCtr( )[ ]
%Ec
' 
( 
) ) 
* 
+ 
, , 
& Ec
+
ER t #$tCtr( )[ ]
%Rc
' 
( 
) ) 
* 
+ 
, , 
& Rc
+1
+ CCc
' 
( 
) 
) 
) 
) 
) 
* 
+ 
, 
, 
, 
, 
, 
#
cyce[ ]
Hc
 (24) 
! 
d CYCE[ ]
dt = Lc cyce t "#tCtl( )[ ] "
CYCE[ ]
HC
       (25) 
Dup may be liberated from the PreRC at the start of S-phase by CycE activity (yellow 
line).  In this, Equation 13 was replaced with: 
! 
d DUP[ ]
dt = Ld + KDG GD[ ] + rAg GD[ ]" APC[ ],#Ag,$Ag( ) + rCs PreRC[ ]" CYCE[ ],#Cs,$Cs( ) %KUD U[ ] DUP[ ]
%KGD GEM[ ] DUP[ ] % rCULd DUP[ ]" CUL[ ],#CULd ,$CULd( ) %
DUP[ ]
HD
 (26) 
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Finally, we explored models that allowed degradation of E2F1 in the ER and ERp 
complexes. Incorporating any of the changes into the model individually or in 
combination did not prevent the model from reproducing any of the experimentally 
observed behavior listed in Table S2, though they did alter the fraction of parameter sets 
doing so (see Supplementary Discussion). 
 
We also explored a model where E2F1 degradation was controlled directly by CycE 
activity (independent of an S-phase or CRL4Cdt2 activity). This model could produce 
oscillations, but overexpression of CycE always resulted in arrest with low E2F1.  In this 
model, we replaced Equation 4 with: 
! 
d E2F[ ]
dt = Le + KER ER[ ] + KERp ERp[ ] "  rCe E2F[ ] # CYCE[ ],$Ce,%Ce( ) "KRE E2F[ ] RBF[ ] "
E2F[ ]
HE
  (27) 
To simulate E2F1PIP3A, we added additional E2F1 that was not degraded by CRL4Cdt2 but 
otherwise behaved identically to E2F1. Equations 5, 6 and 9 were altered, and we added 
E2Fp, the nondegradable E2F1 as described below: 
 
! 
d RBF[ ]
dt = Lr " rCr RBF[ ] # CYCE[ ],$Cr,%Cr( ) + KER ER[ ] + KER EpR[ ] "KRE E2F[ ] RBF[ ] "KRE E2Fp[ ] RBF[ ]
+ rDr RBFp[ ] "
RBF[ ]
HR
 (28) 
! 
d RBFp[ ]
dt = rCr RBF[ ] " CYCE[ ],#Cr,$Cr( ) + KERp ERp[ ] + KERp EpRp[ ] % rDr RBFp[ ] %
RBFp[ ]
HR
  (29) 
! 
d cyce[ ]
dt = Cc" ER[ ] + EpR[ ],#Rc,$Rc( )
1%CCc( )
E2F[ ] + E2Fp[ ]
#Ec
& 
' 
( 
) 
* 
+ 
$ Ec
E2F[ ] + E2Fp[ ]
#Ec
& 
' 
( 
) 
* 
+ 
$ Ec
+
ER[ ] + EpR[ ]
#Rc
& 
' 
( 
) 
* 
+ 
$ Rc
+1
+ CCc
& 
' 
( 
( 
( 
( ( 
) 
* 
+ 
+ 
+ 
+ + 
%
cyce[ ]
Hc
  (30) 
! 
d E2Fp[ ]
dt = Lep + KER EpR[ ] + KERp EpRp[ ] "KRE E2Fp[ ] RBF[ ] "
E2Fp[ ]
HE
    (31) 
! 
d EpR[ ]
dt = KRE E2Fp[ ] RBF[ ] + rDr EpRp[ ] " rCr EpR[ ]  # CYCE[ ],$Cr,%Cr( ) "KER EpR[ ] "
EpR[ ]
HR
  (32) 
! 
d EpRp[ ]
dt = rCr EpR[ ]  " CYCE[ ],#Cr,$Cr( ) % rDr EpRp[ ] %KERp EpRp[ ] %
EpRp[ ]
HR
    (33) 
 
3. Supplementary Discussion 
Finding working parameter sets 
The behavior of our model depended on the parameters governing the interactions within 
the model, none of which have been experimentally measured. To investigate whether 
our model could reproduce wild-type oscillations, we randomized all free parameters 
within biologically plausible ranges, and searched for sets of parameter values that 
reproduced the observed salient features of wild-type oscillations (described below). The 
range of parameter values used in our search is shown in Table S1. We chose wide ranges 
(usually one or two orders of magnitude) to fully explore the biologically reasonable 
range of parameter values7. Additional constraints were placed on some parameter values 
to reflect our knowledge of the system:   
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(1) CRL4Cdt2 activity rapidly degraded E2F1 and Dup, with at least a 5-fold increase 
in degradation over basal rates (
! 
rCULe >
5
He
 and 
! 
rCULd >
5
Hd
). 
(2) Similarly, APCfzr rapidly degraded Gem, with at least a 5-fold increase in 
degradation over basal rates (
! 
rAg >
5
Hg
). 
(3) The complex of E2F1 bound to phosphorylated Rbf had a much faster 
dissociation rate than when bound to non-phosphorylated Rbf (KERp > 5KER).   
(4) Gem bound Dup with high affinity, with an on rate at least 10x faster than the off 
rate (
! 
KGD >10KDG ) and at least 5x faster than the binding of Dup to the 
PreRC(
! 
KGD > 5KND ). 
(5) Cooperativities were restricted to integer values. This does not reflect a biological 
constraint, but numerical solving of our system was much faster with integer 
cooperativities.  Searches allowing non-integer cooperativities did not change our 
results or conclusions. 
Asserting the above constraints served to speed the search for lifelike oscillations; 
relaxing the constraints above merely resulted in a lower frequency of finding working 
parameter sets. We considered a set of parameter values acceptable if the model 
reproduced salient features of wild-type (WT) oscillations, as follows:  
(1) Large amplitude oscillations in E2F1, Gem and CycE protein levels: All of 
these had to have at least a 4-fold change over the course of a cycle.  This was 
consistent with quantification of the nuclear signal from Fig 1 that showed these 
proteins had dramatic changes in cycling cells.   
(2) Non-overlapping, narrow E2F1 & CycE peaks: E2F1 and CycE were not 
simultaneously maximal (i.e. when one is at its maximal value, the other must be 
below half its maximal value), and E2F1 peaked prior to CycE in each cycle, as 
shown by the phase plots in Fig 1.  Consistent with quantification of nuclear 
expression, we also required E2F1 and CycE protein to be at high levels (greater 
than half maximal) for less than 40% of the cycle. 
(3) Overlapping CycE and Gem peaks: Gem and CycE are usually expressed at 
high levels in the same cell. Consistent with observation, when Gem is at its 
maximal value we require CycE to be at least 1/3 its maximal value.  
Additionally, Gem is present at high levels in few cells, and we require Gem 
protein to be at high levels (greater than half maximal) for less than 40% of the 
cycle.   
(4) DNA doubling during each cycle: PreRC formation rose above 75% during G- 
phase and fell below 10% by the end of S-phase. We sometimes observed cycling 
with only modest PreRC variation, and this is inconsistent with the apparent 
doubling of DNA each cycle. 
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Restrictions & constraints on parameters revealed by the model 
We found parameter sets satisfying the above criteria. The fraction of parameter sets 
doing so (hereafter referred to as the hit rate) was approximately 1 in 10,000. Fig S6 
shows histograms of the distribution of parameter values for 1375 parameter sets 
producing lifelike oscillations. For most parameters, WT oscillations were possible across 
the whole explored range, but some parameters had absolute restrictions where values 
outside of a specific range never produced WT cycles. Neglecting the effects of the 
constraints we imposed during our random parameter search (KERp > 5KER, etc), our 
model predicted that the following quantitative constraints were required for WT 
oscillations: (1) CycE transcription was steeply activated by intermediate levels of free 
E2F1 protein (νEc > 1 and κEc > 0.05). The threshold for transcriptional activation of 
CycE by E2F1 (kEc) was not too low (or too graded), or else the basal level of free E2F1 
resulted in a continuous high level of CycE transcription. (2) CycE activation of the 
PreRC was fast (rCp > 0.025) and steeply activated by intermediate levels of CycE (νCs > 
1 and κCs > 0.02). Again, if the threshold for CycE activating the PreRC was too low or 
graded, the basal CycE resulted in immediate firing of PreRCs after licensing. (3) The 
constitutive (non-E2F regulated) rate of CycE production (CCc) was very low to allow for 
large amplitude CycE oscillations.  As the fraction of constitutively transcribed cyce rose, 
E2F1 had a correspondingly weaker ability to modulate CycE activity, and the amplitude 
of CycE oscillations fell. 
It is possible that the large range of working parameter values is due to compensation 
where a particularly large value for one parameter is balanced by a reduced value in 
another. To test the extent of compensation between pairs of parameter values, we 
measured the Pearson product-moment cross correlation coefficient (ρ) between all pairs 
of parameters, shown in Fig S7. Neglecting correlations due to constraints between 
parameters we imposed during our search (i.e. KERp > 5KER, etc.), no pair of parameters 
showed strong correlation (
! 
" # 0.4 ). The lack of correlations indicates that 
compensation is either relatively weak or involves triplets or larger groups of parameters.  
The endocycle network robustly reproduces wild type oscillations  
The endocycle model robustly produced wild-type oscillations despite large changes in 
parameter values. The histograms shown in Fig S6 show that lifelike oscillations were 
produced over large (1-2 orders of magnitude) ranges and with few restrictions on the 
range of parameter values. This hit rate for the endocycle network of 1 in 10,000 is ~2 
orders of magnitude lower than that found in previous studies of the segment polarity and 
neurogenic networks7,9. This difference is likely attributable to the stringency of what 
was required of working parameter sets. In this study, our model had to make oscillations 
that reproduced numerous quantitative features of wild-type oscillations. When additional 
criteria were added to the segment polarity network (i.e. the ability to sharpen a blurred 
initial pattern), the hit rate fell dramatically. If the segment polarity or neurogenic 
networks were required to more carefully match as many quantitative features as we have 
required for the endocycle, their hit rates would likely fall to a comparable level. 
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The endocycle model reproduces the effects of many perturbations and mutations 
We next challenged our model to reproduce the phenotypes of experimental perturbations 
of the endocycle genes. We also used our model to test whether the endocycle rate may 
be slowed by reducing translation rate to mimic starvation. The list of perturbations we 
explored is summarized in Table S2.  Starting with parameter sets that reproduced wild 
type cycles, we simulated the perturbations in Table S2 and recorded the fraction of 
parameter sets satisfying each criterion. We found 12 parameter sets that satisfied all 
these new criteria.  Fig S10 shows the model results for each of the perturbations in Table 
S2 that are not shown elsewhere.  Some criteria were more stringent than others, and we 
discuss our key assumptions and findings below. 
E2F1 overexpression: 
Quantification of E2F1-overexpressing salivary glands showed relatively unchanged 
profiles of E2F1 and CycE expression. The fraction of cells with high E2F1 or high CycE 
did not change noticeably when E2F1 was overexpressed (compared to WT) though the 
level of maximal expression (peak E2F1 or CycE staining) appeared higher.  
Additionally, DNA quantification showed that cycling was faster. After simulating a 
tripling of E2F protein production, we were able to reproduce all of these qualitative 
features in the model that were observed in experiment.   
 
We do not know the factor by which E2F1 protein synthesis was increased in E2F1 
overexpressing glands. E2F1 mRNA was increased by a factor of ~10 as measured by 
qRT-PCR (Fig 3I), but it is quite possible this did not translate to a 10-fold increase in 
E2F1 protein, as the translational machinery may be saturated (or nonlinear) or Dp 
protein levels may become limiting. Thus, a 3-fold increase in E2F1 protein production is 
a reasonable assumption, and several parameter sets continued to reproduce observed 
oscillations when we simulated larger increases in E2F1 overexpression in the model. 
Rbf loss/overexpression: 
Rbf is a potent regulator of E2F1 activity and can arrest the endocycle when 
overexpressed (Fig 2), but is not required as cycling proceeds after the loss of Rbf. Our 
model easily reproduced these results (Fig 2). Sufficiently high Rbf was always sufficient 
to arrest E2F1 and CycE oscillations, as this would result in a complete block of CycE 
production. In the absence of Rbf, the model was able to reproduce WT oscillations and 
the effects of mutations (except those involving Rbf). Usually, elimination of Rbf 
resulted in a slight acceleration of E2F1 and CycE oscillations but otherwise normal 
cycling. Thus, our model suggests that Rbf regulation does not strongly shape normal 
cycling, and its primary function is to arrest cycling when Rbf is expressed at high levels. 
CycE overexpression: 
CycE overexpression was the most difficult perturbation for the model to capture (i.e. it 
had the lowest frequency of parameter sets satisfying reproducing this perturbation).  We 
simulated the addition of constitutively overproduced CycE production in the model.  
Often, CycE overexpression eliminated E2F1 and CycE oscillations, but was 
accompanied by a low but continuous S-phase that resulted from an incomplete block of 
PreRC formation (i.e. the high CycE was not sufficient to completely block Dup through 
APCfzr and Gem activity). We did not observe any BrdU incorporation under conditions 
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of CycE overexpression in experiment. The indicated fraction (2%) of parameter sets 
reproduced all the qualitative features of CycE overexpression. 
Ago loss: 
The F-box protein Archipelago (Ago/Cdc4/Fbw7), which targets CycE for degradation, is 
required for endocycle progression18 (Fig S1). It has also been shown that Cyclin E can 
target itself for degradation by autophosphorylation19, but the detailed regulation of this is 
unclear. Our model usually required unstable CycE protein (Fig S6) to reproduce wild-
type oscillations. When we simulated the effects of the Ago1 mutation by increasing the 
stability of CycE protein (increasing HC by a factor of 10), we were able to reproduce the 
experimentally observed arrest with high CycE.   
Dp mutants: 
As predicted by the computer model, loss of E2F1 essentially abolished endoreplication 
in the salivary gland (Fig S13). Deletion of its designated binding partner Dp might 
therefore be expected to result in a similar phenotype, as predicted by our model (Fig 
S10). It should be kept in mind however that Dp is required in both activating E2F1/Dp 
and repressing E2F2/Dp complexes. Experimentally, we found that Dp null mutant 
salivary gland cells had a much weaker endocycle defect than e2f mutant cells (Fig 2, 
S13, S14, S15). Endoreplication in Dp mutants was significantly delayed, but salivary 
glands showed regular, oscillating patterns of BrdU incorporation and reached normal 
DNA contents by about 180h AED (endoreplication in wild-type is complete and ceases 
at 96h AED). We observed, however, aberrant chromosome morphology in the Dp 
mutants (Fig S15), suggesting that their DNA replication may not be completely normal.  
In our computer simulation, CycE oscillations were always absent whenever E2F1 or Dp 
were eliminated, because E2F1/Dp was the only activator of CycE expression (Fig S10). 
Our model, however, could produce CycE oscillations and periodic S-phases with as little 
as ¼ the normal amount of E2F1, while reproducing all other perturbations in Table S2. 
RT-qPCR showed that overall E2F target gene expression was reduced in Dp mutant 
salivary glands, but transcripts were still detectable (Fig S15). RNA in situ hybridization 
showed normal oscillation of CycE and RnrS transcripts in these mutant glands (Fig S15). 
We also observed normal oscillation of Geminin protein in the Dp mutant (Fig S15). 
Geminin is an APCfzr target that is believed to oscillate because of the periodic repressive 
activity of CycE/Cdk2 on APCfzr, and thus this result implies that CycE/Cdk2 activity 
oscillates in the Dp mutants. Taking these results together, the most likely explanation for 
continued endocycling in the Dp mutants is that residual Dp protein allows continued 
oscillations of E2F activating and repressive transcriptional activity, driving the 
endocycle in essentially the same way as in WT.  
Western blotting experiments revealed trace amounts of Dp protein in salivary glands 
from Dp null mutants (Fig S15), and quantification of these bands indicated that Dp 
mutants contained about 8% of residual Dp protein at 96h and 120h AED (Fig S15). 
Since Dp is thought to be a relatively stable protein, this residual Dp is likely maternally 
derived. To genetically test the presence of maternally derived Dp protein, wild-type 
GFP-E2F1 or non-degradable E2F1 (GFP-E2F1PIP3A) were overexpressed in Dp mutants 
(Fig S16). We found that GFP-E2F1PIP3A was still capable of blocking endocycle 
progression in Dp mutants, although the arrest was less stringent than in wild-type (Fig 
S16). Moreover, expression of non-degradable E2F1 in Dp mutants was associated with 
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severe chromosomal defects (Fig S16). In contrast, the oscillation of S-phase in Dp 
mutants was not affected significantly affected by overexpression of full-length WT 
(degradable) GFP-E2F1 (Fig S16). The ability of wild-type E2F1 to drive accelerated 
endocycling and consequent hyperpolyplody was strongly reduced in the Dp mutants (Fig 
S16), indicating that the reduced amount of Dp protein available to form E2F1/Dp 
complexes had limited the rate of endoreplication. Since all extant data indicate that Dp is 
essential for E2F1 function, we conclude that Dp mutants retain residual amounts of Dp 
protein, which are sufficient to allow slow but otherwise fairly normal endocycles in Dp 
mutants. 
An important question that stills remains to be answered is whether endoreplication can 
occur in complete the absence of E2F/Dp activity. Since our work demonstrated that Dp 
mutants are still likely to contain functional E2F1/Dp complexes, we lack the tools to test 
this idea experimentally. However, we have used our model to address this question 
theoretically. This modeling approach suggested two possible ways in which DNA 
replication might be able to continue without any functional E2F.  First, our model 
predicts the possibility of an extended, slow S-phase triggered by the basal level of CycE 
expression that occurs without E2F1 activation or E2F1/Rbf repression, as shown in 
Figure S10. In such cases, replicated DNA could be relicensed because CycE was too low 
to block licensing through APCfzr and Gem. Table S2 shows the fraction of wild-type 
parameter sets with this behavior, and this continuous replication is compatible with the 
behavior of other mutations, as some parameter sets reproduced all perturbations in Table 
S2. Continuous replication, however, is not consistent with our experimental 
observations, which showed BrdU incorporation in only a fraction of nuclei in Dp mutant 
salivary glands (Fig S14, S16). Second, our model predicts that Dup/CRL4Cdt2 
oscillations may be possible in the complete absence of E2F1. These oscillations rely on 
periodic CRL4Cdt2 activity that removes all Dup. However, such E2F1-independent 
oscillations were rare in our parameter search: Less than 0.01% of parameter sets that 
produced normal cycles (wild-type oscillations in the presence of E2F1) could also 
produce E2F1-independent oscillations when we simulated removal of all E2F1. 
Moreover, we were unable to find any parameter sets that produced E2F1-independent 
oscillations and that also reproduced all perturbations listed in Table S2. We note, 
however, that an E2F1-independent endocycle based on DupßàCRL4Cdt2 feedback 
interactions is theoretically possible. 
E2F1PIP3A: 
To mimic the effects of E2F1PIP3A, we simulated addition of E2F1 that was 
nondegradable by CRL4Cdt2 activity (Equations 30-35).  Endogenous (degradable) E2F1 
was also present, but the simulated E2F1PIP3A (nondegradable) was expressed at twice the 
level in our model. The E2F1PIP3A rapidly accumulated (since it was not periodically 
degraded) and always resulted in continuously high levels of CycE expression, and a 
complete block of S-phase. 
Loss of CRL4Cdt2 activity: 
Is it possible that periodic E2F1 degradation is not required for endocycling?  To test this, 
we examined the behavior of the model when CRL4Cdt2 could not degrade the 
endogenous E2F1, and when CRL4Cdt2 had no activity at all (it degraded neither E2F1 
nor Dup). Conceptually, E2F1 oscillations are possible in such a model, and could arise 
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through periodic stabilization through binding to Rbf (i.e. E2F1 is stabilized by binding 
to Rbf). However, we failed to find any parameter sets that reproduced wild-type E2F1 or 
CycE oscillations despite searching > 200 million parameter sets. This vanishingly small 
hit rate indicates that wild-type oscillations without CRL4Cdt2 require exquisitely tuned 
kinetics (we did not perform an exhaustive search), and therefore such oscillations are 
unlikely to be robust to parameter changes or simulated mutation. Taken together, 
modeling and experiment suggests that endocycles require periodic E2F1 degradation. 
Loss of APC activity and Geminin overexpression: 
Periodic degradation of Gem appears to be required for normal endocycles, as Gem 
overexpression or loss of APCfzr activity both result in cycle arrest/slowing with high 
E2F1 and CycE20. Experimentally, APCfzr activity was eliminated by overexpression of 
the APCfzr inhibitor Rca1, and we simulated this in the model by blocking the activity of 
APCfzr (i.e. so it could no longer degrade Gem). We simulated Gem overexpression by 
increasing Gem synthesis by a factor of 10. Our model was able to reproduce the 
observed arrest with high E2F1 and CycE with both perturbations, consistent with 
experiment.    
Starvation control of rate of cycling: 
We simulated starvation conditions by reducing all translation rates (L parameters) by 
33%, and requiring cycling continue, but at a slower rate. Our model was able to 
reproduce this, and with additional translation reduction, the cycle eventually arrested 
with no DNA replication.  Our model predicts that translational throttling through 5’UTR 
regulation is a viable way to control the rate of cycling21,22. We explored the effect of 
individual parameters on the rate of cycling as discussed in the next section.  
Sensitivity of endocycle rate to parameter changes 
We systematically perturbed each model parameter to see what parameters most strongly 
affect the rate of cycling. We started with the 12 parameter sets that reproduced all 
mutations and measured the change in period when a parameter was lowered by 10% 
while all other parameters were held fixed. This process was repeated for all parameters, 
and the average fractional change in period for each perturbation was recorded. If a 
perturbation resulted in cycle arrest, it was excluded from the average.  Fig S8 shows the 
average effect of a 10% reduction of each parameter on the period. 
The model indicates that slowing of the cycle during starvation is mostly due to changes 
in the E2F1 or CycE transcriptional synthesis rates (Le, or Lc); throttling translation of 
Gem, Dup and Rbf had little effect on the period. The model indicated that there are 2 
additional strategies that would allow for the period to be tuned:  First, slowing the global 
kinetics of E2F1 accumulation during G phase would slow the cycle as it would take 
longer to trigger CycE production. This could be accomplished by reducing the amount 
of E2F1 (by decreasing the mean lifetime of the E2F1 protein HE, reducing translation 
Le), or decreasing its activity (raising κEc). Second, the endocycle could be sped by 
shortening S-phase (ΔtS) or its effect on CRL4Cdt2: shortening the active lifetime of 
CRL4Cdt2 (HCUL), lowering the threshold for E2F1 degredation (κCULe), or lowering the 
threshold for CRL4Cdt2 activation (κScul). 
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Robustness of parameter sets reproducing all perturbations 
To analyze the sensitivity of the model to parameter perturbation, we systematically 
varied individual parameters one at a time within each of 28 parameter sets that 
reproduced the observed effect of all mutations in Table S2.  Each parameter (except for 
cooperativities) was varied from 0.1 to 10 times its original working value, while the 
other parameters were held fixed. The fraction of parameter sets that continued to 
produce oscillations (stable oscillations with a 2-fold change in CycE over a cycle) over 
at least 1 full order of magnitude is shown in Fig S9. On average, 90% of parameters 
could tolerate an order of magnitude variation (i.e. continue to produce oscillations over 
at least a 10-fold variation in the given parameter). Part of this robustness reflects the 
criteria in Table S2:  these parameter sets must, for example, tolerate substantial E2F1 
and Rbf variation, but many parameters (such as delays and activities) had no such 
constraints. Our model strongly suggests that the endocycle network present in cycling 
cells is extremely robust to parameter perturbation.   
Identifying essential regulatory interactions  
We also constructed variations of our model that incorporated additional or alternate 
regulation (see Supplementary Methods) and explored whether these models were able to 
continue to reproduce experiment. This allowed us to identify which regulatory features 
were essential for reproducing experiment; if models continued to reproduce experiment 
after a change to the model, then th change reflects a detail unimportant to capture lifelike 
behavior. Expression of Dup is possibly regulated by E2F1, and we tested whether such 
regulation would change the behavior of our model.  Models incorporating this regulation 
were capable of reproducing WT oscillations and all mutant effects in Table S2, so our 
model indicates the specifics of Dup are not essential. We explored models were Dup 
was released from the PreRC at the start of S-phase and a simplified network where the 
effects of Gem and APCfzr were abstracted by having CycE activity directly block PreRC 
formation. These models were also able to reproduce WT oscillations and all mutations in 
Table S2. These findings indicate that the ability to reproduce experiment is not an 
artifact of a carefully optimized network.   
Some perturbations to the model eliminated its ability to reproduce all behavior. As 
described previously, periodic E2F1 degradation by CRL4Cdt2 is essential for producing 
normal cycles. It has also been hypothesized that E2F1 is phosphorylated and 
destabilized by CycE. We explored a model variant where high levels of CycE, but not 
CRL4Cdt2 caused degradation of E2F1, and found that it could produce normal cycles, but 
failed to arrest with high E2F1 when CycE was overexpressed. Taken together, our 
model predicts that periodic E2F1 degradation during S-phase is essential.  Future models 
could also explore the effects of CycE degradation through autophosphorylation and Ago 
activity. Our model indicates these effects are not required for normal cycling, as lifelike 
behavior is generated without their inclusion. 
Delays shaped the CycE expression during the endocycle 
Our model allowed us to investigate the effects of changing the time delay in CycE 
production. Fig S8 indicates that the CycE transcriptional and translational delay (ΔtC) 
could usually be varied by an order of magnitude without disrupting cycling, indicating 
that the model can robustly produce lifelike oscillations regardless of the delay. One 
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would expect that the duration of the delay could affect the period of the endocycle; 
elimination of the delay would allow CycE to rise faster in response to E2F1 and lead to 
faster cycling. This intuition is confirmed in Fig S8 where we show that a 10% reduction 
in these delays resulted, on average, in a mild speeding of the cycle.   
If endogenous CycE were replaced by a cDNA (with the endogenous promoters & 
regulator sites present but lacking introns), our model predicts that the endocycles 
produced may be detectably altered. Introns account for up to 2/3 of the cyce transcript23, 
and so their removal may reduce the delay between transcriptional initiation and the start 
of translation. If we assume that the total delay is reduced by a factor of 2, our model 
predicts that the cycle time should always decrease, speeding the cycle by 2-8% (mean = 
5%) in parameter sets that satisfy all criteria in Table S2.  Such a shift, while small, could 
result in an additional endocycle during development and thus produce a noticeable 
change. 
 
4. Supplementary Tables 
Table S1: Parameters in model 
All parameters in the main model are listed below. The working value was used to 
generate all graphs of model behavior shown in the main paper and Fig S10, 
perturbations to parameters to mimic experiment are detailed in Table S2.  These 
parameters have not been experimentally measured, so we used a Monte-Carlo search 
over the specified range and sampling distribution shown.   
Symbol Description Working 
Value 
Range, sampling 
for Random Search 
  
CycE transcriptional regulation: 
  
κEc E2F1 concentration for half maximal CycE transcription 0.41 0.01-1, Log 
νEc Cooperativity of E2F1 on CycE transcription 7 1-8, Integer 
κRc E2F1/Rbf dimer half maximal inhibition of CycE transcription 0.087 0.01-1, Log 
νRc Cooperativity of E2F1/Rbf dimer on CycE transcription inhibition 1 1-8, Integer 
ΔtC Delay in CycE transcription & translation 15 1-5, Log 
  
GEM regulation: 
  
rAg Maximal rate of APCfzr degradation of Gem 0.22 0.1Lg -10Lg, Log 
κAg APCfzr half maximal degradation of Gem 0.28 0.01-1, Log 
νAg Cooperativity of APCfzr degradation of Gem 7 1-8, Integer 
  
APCfzr regulation: 
  
rA Rate of spontaneous APCfzr activation 0.016 0.005-1, Log 
rCa Maximal rate of APCfzr inactivation by CycE 646 1/rA -25/rA, Log 
κCa CycE half maximal inactivation of APCfzr 0.74 0.2κCs -1.5κCs, Log 
νCa Cooperativity of CycE on APCfzr inactivation 4 1-8, Integer 
  
DNA licensing & S-phase: 
  
KUD Rate of Dup binding to U 0.12 0.005-1, Log 
rCs Maximal rate of PreRC firing (S-phase initiation) by CycE 0.063 0.005-1, Log 
κCs Half maximal CycE for triggering S-phase 0.065 0.01-1, Log 
νCs Cooperativity of CycE on triggering S-phase 3 1-8, Integer 
ΔtS Time delay between PreRC firing and completion of S-phase (return to U) 40 20-50, Linear 
  
CRL4Cdt2 regulation & activity: 
  
κCULe Half maximal CRL4Cdt2 for destroying E2F1 0.068 0.01-1, Log 
νCULe Cooperativity of CRL4Cdt2 on destroying E2F1 5 1-8, Integer 
rCULe Maximal rate of E2F1 degradation by Cul4 activity 0.29 5Le -25Le, Log 
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κCULd Half maximal CRL4Cdt2 for destroying Dup 0.11 0.01-1, Log 
νCULd Cooperativity of CRL4Cdt2 on destroying Dup 1 1-8, Integer 
rCULd Maximal rate of Dup degradation by CRL4Cdt2 activity 0.72 5Ld -25Ld, Log 
κScul Half maximal S for activating CRL4Cdt2 0.11 0.01-1, Log 
νScul Cooperativity of S on activating CRL4Cdt2 7 1-8, Integer 
rScul Maximal rate of CRL4Cdt2 activation by S-phase 0.08 0.005-1, Log 
HCUL Mean lifetime of active CRL4Cdt2 10.4 5-200, Log 
  
Regulation of Rbf: 
  
κCr CycE concentration for half maximal Rbf phosphorylation 0.011 0.01-1, Log 
νCr Cooperativity of CycE on Rbf phosphorylation 5 1-8, Integer 
rCr Rate of Rbf phosphorylation by CycE 0.050 0.01-2, Log 
rDr Rate of Rbf dephosphorylation 0.074 0.01-1, Log 
  
Dimerization & cleavage rates: 
  
KRE Rate of E2F1 Rbf dimerization 0.01 0.005-1, Log 
KER Rate of E2F1/Rbf dimer dissociation 0.076 0.005-1, Log 
KERp Rate of E2F1/Rbf p dimer dissociation 0.75 10KER -100KER, Log 
KGD Rate of Gem Dup dimerization 2.68 5KUD -25KUD, Log 
KDG Rate of Gem/Dup dimer dissociation 0.026 0.01KGD -0.1KGD, Log 
  
Mean Lifetimes of mRNA & proteins: 
  
HE Mean lifetime of E2F1 49.6 5-200, Log 
HR Mean lifetime of Rbf 47.6 5-200, Log 
Hc Mean lifetime of CycE mRNA 15.7 5-100, Log 
HC Mean lifetime of CycE 15.6 5-200, Log 
HG Mean lifetime of Gem 122 5-200, Log 
HD Mean lifetime of Dup 72.9 5-200, Log 
  
Transcription & translation rates: 
  
Le E2F1 synthesis rate 0.02 1/HE, Fixed 
Lr Rbf synthesis rate 0.13 0.05/HR-20/HR, Log 
Cc CycE transcription rate 0.06 1/Hc, Fixed 
CCc Basal CycE transcription in absence of E2F1 activation 0.014 0.01-0.2 
Lc CycE translation rate 0.06 1/HC, Fixed 
Lg Gem synthesis rate 0.027 0.1/HG -100/HG, Log 
Ld Dup synthesis rate 0.090 0.1/HD -10/HD,Log 
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Table S2: Fraction of lifelike parameter sets that satisfy perturbation 
Perturbation Model perturbation Required effectReference % of WT 
parameter sets 
satisfying criteria 
E2F1 overexpression Increase E2F1 synthesis  
(Le x 3) 
Cycle fasterFig 2 16% 
Rbf loss of function Eliminate Rbf protein  
(Lr = 0) 
Cycle continues24 93% 
Rbf overexpression Increase Rbf synthesis  
(Lr x 10) 
Arrest with high E2F1 and 
low CycE 
50% 
CycE overexpression Add constitutively produced 
CycE  
 
Arrest with high CycE, 
GEM, and E2F1Fig 2 
2% 
Ago loss of function Increase CycE protein stability  
(HC x 10) 
Slow/arrest with high 
CycEFig S1 
25% 
Dap overexpression Eliminate CycE protein 
activity  
(rCr = 0, rCs = 0, rCa = 0) 
Arrest with high E2F1Fig2 100% 
Starvation slow Decrease all translation by 
33% (E2F1, Rbf, Gem, Dup 
and CycE) 
(All L x 0.67) 
Cycle slows, hypothesized 
as a way to regulate 
period21,22 
46% 
Starvation arrest Decrease all translation by 
80% (E2F1, Rbf, Gem, Dup 
and CycE) 
(All L x 0.2) 
Arrest with low E2F1 and 
CycEFig 4 
83% 
Dp loss of function Eliminate E2F1 protein  
(Le = 0) 
Cycle slows but does not 
completely arrestFig 2 
4% 
E2F1PIP3A Add E2F1 that cannot be 
degraded by CRL4Cdt2 activity  
(Lep = 2 Le) 
Arrest with high E2F1 and 
high CycEFig 2, Fig 3 
99% 
Loss of CRL4Cdt2 No CRL4Cdt2 activity  
(rCULe = 0, rCULd = 0) 
Arrest with high E2F1 and 
high CycE 
100% 
Loss of APCfzr 
function 
Elimination of APCfzr 
degradation of Gem  
(rAg = 0) 
Cycle slows/arrests with 
high E2F1 and CycE 
activity20 
6% 
Gem overexpression Add constitutively produced 
Gem 
(Lg x 10) 
Cycle slows/arrests with 
high E2F1 and CycE20 
10% 
All of above The parameter set reproduces the effect of each perturbation 
above 
0.004 % 
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5. Supplementary Figures 
Figure S1: SCF/Ago-mediated degradation is essential for endocycle progression 
 
Figure S1: L3 salivary gland (96-104h AED) containing a cell mutant for the F-Box 
protein archipelago (cell enclosed in dotted line). Ago1 mutant cells were generated by 
mitotic recombination and were marked by the absence of GFP expression. The asterisk 
indicates the twin-clone containing two copies of the ub-GFP construct. A) DNA staining 
reveals that ago1 mutant cells have smaller nuclei than the adjacent control cells, 
indicating that the SCFAgo complex is essential for endocycle progression in salivary 
glands. C-D) By this time (96-104h AED), salivary gland cells have exited the endocycle 
and have no Cyclin E protein. However, Cyclin E protein persists in ago1 mutant cells, 
demonstrating that the SCFAgo complex is essential for Cyclin E degradation in larval 
salivary glands. E-F) Ago1 mutant cells display MPM-2 positive nuclear spheres, which 
are characteristic for cells with high levels of CDK activity.  Scalebar: 50µm. 
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Figure S2: dacapo mutant salivary glands can endocycle normally 
Figure S1: A) Dap protein levels are reduced 
in larval salivary glands. Extracts from em-
bryos and salivary glands of indicated time 
after egg deposition were analyzed by 
Western blotting using antibodies against 
Dap and Tubulin. Ponceau S staining shows 
total protein levels. The number of embryos 
or salivary glands per lane is indicated. 
Lanes 2, 7, and 9 show similar staining for 
tubulin and Ponceau S. In larval salivary 
glands (lines 7 and 9), however, only trace 
amounts of Dap protein are present. B-D) 
dap4/dapg36 mutant larva had ~7% viability 
to the wandering L3 stage (103-108 hrs 
AED) and most showed a 10-20 hr delay in 
pupariation (data not shown).  B) Although a 
significant fraction of dap4/dapg36 mutant 
larvae were smaller than controls 
(dap4/CyO,Act-GFP or dapg36/CyO, Act-
GFP) at all larval stages, some dap4/dapg36 
mutants were normal size, consistent with 
normal rates of endocycle progression in 
many larval tissues. C) At the L3 wandering 
stage, the size (squares) and DNA content 
(circles) of salivary glands from dap4/dapg36 
fell within the same range as heterozygous 
controls, though the average gland size and 
DNA content were reduced. D) DNA stain-
ing showing examples of salivary glands 
(left), and close-up of single nucleus (right), 
from a control dapg36/CyO, Act-GFP and a 
dap4/dapg36 mutant at the wandering L3 
stage (103-108 hrs AED). A likely cause of 
the growth delay in dap mutants are defects 
in the nervous system that affect feeding or 
systemic metabolism. The variable effects 
seen in the salivary glands could be 
secondary and non-cell autonomous. 
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Figure S3: Phasing of CycE, Gem, and E2F1  
 
Figure S3: Graphs showing nuclear concentrations of E2F1, Gem, CycE and the S-phase 
marker EdU measured from micrographs of 5-8 salivary glands, in which each dot 
represents one nucleus. A) Consistent with the idea that Gem accumulation relies on 
CycE-dependent APC inhibition, we found significant overlap between CycE and Gem 
stainings at 72-74h AED. B) E2F1 and Gem signals were mutually exclusive at 72-74h 
AED, supporting the model that E2F1 protein disappears in S-phase. C-D) GFP-E2F1 
overexpressed under control of the ptc-Gal4 showed a cell cycle distribution similar to 
endogenous E2F1 B). At 84-86h AED a fraction of S-phase cells (EdU-positive) with 
persisting GFP signal was noticeable. These cells presumably represent cells in which the 
level of GFP-E2F1 exceeded the capacity of the CRL4Cdt2 ubiquitin ligase and that will 
eventually arrest the endocycle. 
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Figure S4: Full schematic of endocycle network 
 
Figure S4:  Schematic of the full endocycle network showing the regulatory interactions 
and biomolecules in our model. mRNAs are indicated by lowercase ovals, proteins by 
uppercase squares, the state of the replication complex(licensing) by octagons, and 
heterodimers by connected squares. Solid lines indicate fluxes with the arrow pointing 
towards the product, dashed lines are regulatory interactions, activators end in 
arrowheads, inhibitors end in bars, large arrows indicate constitutive production, ground 
symbols indicate regulated degradation.  Black lines show interactions in the standard 
model; we also explored the effects of alternate regulatory interactions shown with 
colored lines and shapes. APCfzr and CLR4Cdt2 transition between active and inactive 
forms.  All mRNA and proteins (except APC and CLR4Cdt2) decay independently with 1st 
order kinetics. 
Figure S5: Implementation of time delays 
 
Figure S5: Time delays were implemented as a long series of sequential processes that 
produce an effective time delay with mild lowpass filtering. Plot shows an example of 
time delayed CycE mRNA concentration.  Red line indicates non-delayed trajectory, with 
successive colors (cycling from red to blue) showing increasingly delayed versions 
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calculated according to Equation 3. We chose a cascade of N = 10, as this balanced 
computation speed with little attenuation of the non-delayed waveform.  
Figure S6: Histograms of parameter values enabling lifelike oscillations in model 
 
 
Figure S6: Histograms of parameter values (n = 1375) that enabled lifelike oscillations 
(i.e. that reproduced our measurements of wild type cycles). Horizontal axes are plotted 
on a log scale (except those for cooperativities), and the vertical axis represents the 
relative frequency of each parameter value plotted on a linear scale.  For some parameters 
only a limited range of values produced wild type oscillations in our model. All 
parameters are defined with sampled ranges in Table S1.  
 29 
Figure S7: Cross Correlations between parameters 
 
Figure S7: Pairwise cross correlation coefficients in 1375 parameter sets producing wild 
type oscillations. A cross correlation coefficient of 1 (white) indicates complete 
correlation, -1 indicates complete anticorrelation (black), and 0 is uncorrelated. Elements 
along the main diagonal correlate with themselves and thus have a value of 1. All of the 
strong correlations were due to restrictions on the parameters imposed during the random 
search as described in Table S1. Most correlation coefficients were close to 0 indicating 
that compensation, if present, involved groups of 3 or more parameters.   
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Figure S8: Effect of parameters on cycle period 
 
Figure S8: The effect of reducing each parameter on the period of oscillation. We 
perturbed 12 parameter sets producing wild-type oscillations and all criteria in Table S2.  
For each of the parameters, we reduced its value by 10% while keeping all others 
unchanged, and calculated the ratio of the new period to the original period.  Results were 
averaged across all parameter sets. A value of 1 indicates no net change in period, greater 
than 1 indicates the period increases as the parameter is reduced, less than 1 indicates 
period decreases as the parameter is reduced.  
 
 
 
Figure S9: Robustness to parameter perturbation. 
 
Figure S9: The endocycle network produces oscillations that are robust to changes in 
single parameters. Starting with the 12-parameter sets that reproduce wild-type 
oscillations and all the phenotypes of all perturbations in Table S2, we varied each of the 
parameters over 2 orders of magnitude in 8 steps. The fraction of parameter sets that 
could be varied by at least an order of magnitude (10-fold change) and continue cycling 
is plotted on the Y-axis (1 = 10-fold change always tolerated, 0 = 10-fold change never 
tolerated).  
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Figure S10: Endocycle model reproduces experimental perturbations 
 
Figure S10: All panels show the same parameter set showing the effect of perturbations 
in Table S2. The E2F1 line shows the concentration of all forms of E2F1/Dp (sum of all 
free E2F1, E2F1 bound to Rbf, and E2F1PIP3A). All concentrations are normalized to their 
maximal value during steady state oscillation during wild-type (control) cycling. Note 
different vertical axes ranges between plots; horizontal (time) axis is constant for all 
plots. 
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Figure S11: Endocycle arrest by E2F1 stabilization 
 
Figure S11: A) C-values of individual nuclei in the indicated genotypes of salivary 
glands, measured at 96-98h AED. Overexpression of GFP-E2F1 led to higher C-values 
than measured in wild-type salivary glands, while overexpression of GFP-E2F1PIP3A or 
Cul4-RNAi resulted in significantly lower DNA contents. B-C) Matched exposure 
images of GFP-E2F1 (B) and GFP-E2F1PIP3A (C) in salivary glands at 96-98h AED as 
used for fluorescence intensity measurements, shown as an intensity heat-map. D) GFP 
fluorescence intensity measurements displayed as mean pixel intensity/nucleus as shown 
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in B and C, assayed by confocal microscopy with Avalanche Photodiode Detectors. Each 
dot represents the mean GFP intensity/pixel for one nucleus. 324 nuclei from 5 glands 
were measured for GFP-E2F1, and 577 nuclei from 6 glands were measured for GFP-
E2F1PIP3A, both at 96-98h AED. GFP-E2F1 (B’) was expressed at higher levels than 
GFP-E2F1PIP3A (C’) with mean GFP intensities of 23.69 vs. 7.26. See methods for further 
details of the measurement technique. 
Figure S12: Endocycle arrest by Cul4-RNAi 
 
Figure S12: ptc-Gal4-mediated overexpexpression of Cul4-RNAi. Salivary glands were 
analyzed at 72-74h and 96-98h AED. Scale bars = 50µm. A-B) Cul4-RNAi suppressed 
DNA replication, indicated by diminished BrdU incorporation  (A’, B’) and no noticeable 
accumulation of mass between both time points. C-D) Cul4-RNAi caused accumulation 
of E2F1 at early and late time points (C’, D’), while Geminin was only observed at late 
time points (C”, D”). The delay between E2F1 stabilization and appearance of Geminin, 
suggests that the accumulation of Geminin is rather a consequence than the actual cause 
of endocycle arrest. Dashed lines indicate the regions shown in the close-ups in C and D.  
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Figure S13: E2F1 is essential for endocycle progression 
 
Figure S13: A-B) Two examples of mosaic salivary glands containing e2f7172 mutant 
cells. Mitotic recombination was induced in the salivary placode at 2-4h AED. Salivary 
glands were dissected 96-98h AED and subsequently stained with DAPI (blue) to 
visualize DNA contents. Scale bars = 50µm. Cells heterozygous for e2f7172 express one 
copy of GFP (green). Cells homozygous for the e2f7172 allele were marked by absence of 
GFP (arrow heads), while the corresponding wild-type sister clones were labeled with 
two copies of GFP (asterisks). Loss of E2F1 resulted in small cells with vastely reduced 
DNA contents compared to the neighboring control cells (see also Fig 2B). Consistent 
with E2F1’s proposed function as a pacemaker of the endocycle, e2f7172 heterozygous 
cells had about half the DNA content of wild-type (e2f+/ +) cells (B).  
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Figure S14: Endocycle progression is delayed in Dp mutants 
 
Figure S14: Photomicrographs showing endocycle progression in wild-type and Dp 
mutant salivary glands. Salivary glands were dissected at the indicated time points (upper 
right corner) and labeled for 1h with BrdU to visualize ongoing DNA replication. Scale 
bars = 50µm. A-C) At 72-74h and 84-86h AED BrdU incorporation was readily 
detectable in a large fraction of cells, while at 96-98h AED most of the cells had exited 
the endocycle and were thus negative for BrdU staining. D-F) Micrographs of 
representative salivary glands of three different combinations of Dp alleles. From DNA 
sequence, Dpa2 and Dpa3 are believed to be null alleles, and Dpa1 is a strong hypomorph. 
Loss of Dp resulted in a severe delay of salivary gland growth. At 120-122h AED BrdU 
incorporation was readily detectable (D-F), while wild-type salivary glands have 
completed endoreplication at about 96-98h AED (C). Comparison of salivary gland sizes 
showed that at 120-122h AED salivary glands in Dp mutants (D-F) had only reached a 
stage corresponding to wild-type salivary glands at 84-86h AED. 
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 Figure S15: Dp mutants show normal oscillation of E2F target genes 
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Figure S15: A-D) High magnification micrographs of nuclei from wild-type and Dpa2/a3 
mutants. To compensate for differences in developmental timing wild-type was analyzed 
at 84-86h AED, while Dpa2/a3 mutants were aged to 120-122h AED. Scale bars represent 
50µm. Loss of Dp resulted in aberrant chromosome morphology in the salivary gland (A-
B) and the adjacent fat body (C-D). E) The western blot on the left side shows extracts 
derived from the following samples: lane #1: wild-type salivary glands 84-86h AED, lane 
#2: Dpa2/a3 mutant salivary glands 96-98h AED, lane #3: Dpa2/a3 mutant salivary glands 
120-122h AED, lane #4: wild-type S2-R+ cells, lane #5: S2-R+ cells transfected with Dp-
FLAG-HA, lane #6: wild-type S2-R+ cells, lane #7: S2-R+ cells transfected with Dp-
FLAG-HA. Lanes #1-5 were probed with an anti-dDP antibody while lanes #6-7 were 
treated with an antibody against HA-tag. For normalization all lanes were also probed 
with an anti-tubulin antibody, which was detected in a separate channel. In wild-type 
(lane #1 & 4) a strong band was visible at around 50kD, which is the predicted size of 
Dp. In Dpa2/a3 mutants (lane #2 & 3), however, only trace amounts of Dp protein were 
detectable. Ectopic expression of a FLAG-HA tagged Dp construct in S2-R+ led to an 
additional lower mobility band that was also detected with an antibody directed against 
the HA tag (Lane #7). Therefore, we conclude that the anti-Dp antibody specifically 
recognized Dp protein. The graph on the right shows the relative amounts of Dp protein 
normalized to the tubulin signal. This quantification revealed that Dpa2/a3 mutant salivary 
glands still contained ~10% of the Dp protein that was detected in wild-type salivary 
glands. F) Relative expression analysis of E2F target genes mRNAs in Dpa2/a3 mutants, as 
measured by RT-qPCR. Total mRNA from Dpa2/a3 mutant salivary glands was isolated 
96-98h and 120-122h AED. Both time points were compared to mRNA pools from 82-
84h AED wild-type salivary glands. In the Dpa2/a3 mutant levels of Dp transcripts were 
significantly reduced compared to wild-type, while the amount of E2F1 mRNA was 
unaffected. In addition, the expression levels of the E2F target genes CycE, rnrS and 
pcna were significantly reduced compared to wild-type. G-H) Spatial expression of CycE 
transcripts in wild-type and Dpa1/a2 mutants analyzed by RNA in situ hybridization. In 
wild-type (84-86h AED) CycE was expressed in discrete domains (G). In Dpa1/a2 (84-86h 
AED) mutants CycE transcript was present at lower levels but the “oscillating” (on/off) 
pattern of CycE expression was similar to wild-type (H). I-J) Expression pattern of rnrS 
transcripts in wild-type (84-86h AED) and Dpa2/a3 mutant salivary glands (120-122h 
AED). rnrS mRNA is shown in red, DNA staining (DAPI) in blue. Scale bars represent 
50µm. In wild-type and in the Dpa2/a3 mutant rnrS was only detectable in a subset of 
cells, demonstrating that this allelic combination does not prevent oscillation of this E2F 
target gene. K-L) Geminin protein oscillation in wild-type (84-86h AED) and Dpa2/a3 
mutant salivary glands (120-122h AED). Geminin protein is shown in red, DNA staining 
(DAPI) in blue. Scale bars = 50µm. In wild-type and in the Dpa2/a3 mutants Geminin 
protein was only visible in a fraction of cells. Since accumulation of Geminin protein 
requires high levels of CycE/Cdk2 activity, this experiment further supports the idea that 
the Dpa2/a3 mutant allows oscillation of E2F1 target genes. 
 
 
 
 
 
 38 
Figure S16: Overexpression of stable E2F1 prevents endoreplication in Dp mutants 
 
Figure S16: A-C) Salivary glands of the indicated genotypes were labeled for 1h with 
EdU at 96-98h AED. GFP-E2F1 fusion proteins were visualized by staining with a GFP 
antibody. hey-Gal4 was used for salivary gland-directed expression of UAS target genes 
in the Dpa2/a3 mutant. Experiments were performed at 29˚C to allow maximal activation 
of the UAS constructs by Gal4. In the overlays in the right column EdU labeling is shown 
in red, GFP staining in green and DNA staining (DAPI) in blue Scale bars = 50µm. A) 
Despite being delayed in development, Dpa2/a3 mutants showed a fairly normal pattern of 
DNA replication. B) S-phase progression in Dpa2/a3 mutant salivary glands was not 
affected by overexpression of GFP-E2F1 (compare EdU labeling in A’ and B’). C) 
Overexpression of stable E2F1 (GFP-E2F1PIP3A) blocked endocycle progression in 
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Dpa2/a3 mutant salivary glands as indicated by the absence of EdU incorporation (C’). 
Moreover, overexpression of non-degradable E2F1 caused severe defects in chromosome 
morphology C). D) Quantification of C-values per nucleus for the indicated genotypes 
and time points. Average C-values are listed within each bar. Overexpression of stable 
GFP-E2F1PIP3A in the Dpa2/a3 background resulted in a dramatic decrease in nuclear DNA 
content compared to the Dpa2/a3 mutant alone, while DNA content was only mildly 
increased upon overexpression of wild-type GFP-E2F1.  
Figure S17: Geminin mutant cells endocycle 
 
Figure S17: Micrographs showing representative salivary glands from wild-type animals 
(A) and three different combinations of geminin alleles, at 96-98h AED. Second column 
shows the imaginal ring (arrowheads), whose cells undergo mitotic division. Third 
column shows regions boxed in first the first column. Scale bars = 50µm. Average 
amount of DNA/nucleus is shown in Fig 3E. A) Wild-type salivary glands after 
completion of the endoreplication program. In wild-type, imaginal rings were comprised 
of ~200 cells. B) Salivary glands homozygous for the gem allele l(2)k14019 are slightly 
reduced in size, but show normal DNA morphology (B’’). The imaginal rings consist of 
only few cells with highly over-replicated DNA. C) Salivary glands heterozygous for the 
gem alleles l(2)k14019 and l(2)k03202 show normal DNA morphology, while the 
imaginal rings are over-replicated. D) Hemizygous animals carrying the l(2)k14019 allele 
and the deficiency Df(2R)ST1 showed a similar phenotype than animals homzygous for 
l(2)k14019 (B), suggesting that l(2)k14019 represents a null allele or at least a strong 
hypomorph. It is important to note that gem mutant amimals failed to devolop imaginal 
discs and thus the reduced size of the salivary glands is likely due to a delay in overal 
development. 
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Figure S18: Cyclin E but not Rca1 blocks endocycling in gem mutants 
 
Figure S18: Salivary glands of the shown genotypes, stained as indicated, at 96-98h 
AED. 43B-Gal4 was used for salivary gland-directed expression of UAS target genes. 
Gem-/- indicates the gemiminl(2)k14019/gemiminl(2)k14019 genotype. Arrowheads in third and 
fourth columns (’’, ’’’) mark the mitotic imaginal ring, which is defective in gem 
mutants. Scale bars = 50µm. A) Gem mutants displayed normal DNA morphology and 
BrdU incorporation. B-C) Overexpression of CycE prevented S-phase in wild-type (B’) 
and gem mutant salivary glands (C’). D-E) Inhibition of APC activity by HA-Rca1 
overexpression blocked endocycle progression in otherwise wt salivary glands (D’). S-
phase inhibition by HA-Rca1 was suppressed in the gem mutant, as shown by BrdU 
incorporation (E’).  F-G) Antibody staining against the HA epitope revealed that HA-
Rca1 was expressed at comparable levels in wild-type and gem mutant salivary glands. 
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Figure S19: Loss of Gem does not rescue endocycle arrest caused by stable E2F1 
 
Figure S19: Salivary glands of the indicated genotypes, stained as noted, at 96-98h AED. 
43B-Gal4 was used to drive salivary gland expression of the indicated UAS constructs. 
Gem-/- indicates the gemiminl(2)k14019/ gemiminl(2)k14019 genotype. Scale bars = 50µm. A-B) 
Overexpression of GFP-E2F1 allowed S-phase progression in wild-type (A’) and gem 
mutant (B’) salivary glands, as visualized by EdU labeling. C-D) Overexpression of 
stabilized E2F1 (GFP-E2F1PIP3A) blocked nearly all EdU incorporation in both wild-type 
(C’) and gem mutant (D’) salivary glands. Arrowheads in the fourth column (‘“) mark the 
mitotic imaginal ring, which shows defective cell proliferation in gem mutants. E-H) 
Maximum projections of representative nuclei of the same genotypes as above. Scale bars 
= 50µm. E-F) Overexpression of GFP-E2F1 in wild-type or gem mutant salivary glands 
did not affect DNA morphology. G) Overexpression of GFP-E2F1PIP3A caused severely 
disrupted nuclear morphology. H) Although loss of gem did not fully rescue the 
endocycle arrest caused by stabilized E2F1, a less aberrant DNA morphology was 
observed, demonstrating that ectopic accumulation of Geminin accounts for at least part 
of the phenotype.  
 42 
Figure S20: Cyclin A and Cdk1 accumulation after E2F1 overexpression 
 
Figure S20: Wild-type (A-B) and E2F1 overexpressing salivary glands at 72-74h AED. 
First column shows GFP signals (green) from GFP-E2F1 (C-D) or GFP-E2F1PIP3A (E-F) 
and DAPI (blue). Second column shows the levels of Cyclin A (A’, C’, E’) or Cdk1 
protein (B’, D’, F’) detected with anti-PSTAIRE antibody. Third column (“) shows 
regions boxed in second column (‘). Scale bars = 50µm. A-B) In wild-type salivary 
 43 
glands, a high levels of Cyclin A and Cdk1 were detected only in the mitotic imaginal 
ring cells, but absent in the endoreplicating cells of the salivary gland (A’, A”). C-D) 
Upon ectopic expression of GFP-E2F1 Cyclin A as well as Cdk1 staining was visible in 
scattered cells throughout the salivary gland, whereby the signal was strongest in the 
small, arrested cells. E-F) Overexpression of GFP-E2F1PIP3A led to high levels of Cyclin 
A and Cdk1 throughout the salivary gland. 
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